,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes,source,Enrichment_Term,score,significance_str,immune_related
5,prerank,KEGG_2021_Human__Ribosome,-0.5994825174163297,-2.4694017971757667,0.0,0.0,0.0,58/117,18.33%,RPS16;RPS27A;RPL26;RPS29;RPL31;RPL3;FAU;RPS8;RPS15;RPL12;RPL30;MRPL33;RPS20;RPS23;RPS13;RPL35;RPL27A;RPL13A;RPS18;RPS28;RPL37A;RPL22;RPS25;RPLP2;RPL18;RPS17;RPS19;RPL28;UBA52;RPL7A;RPS21;RPL34;RPL36;RPS7;RPL39;MRPL34;MRPL14;RPL37;RPS4Y2;RPL23A;RPL21;RPL9;RPS24;RPS3;RPL7;RPL5;RPL36AL;RPL38;RPL23;MRPS21;RPS14;RPL8;RPL10;MRPL18;RPL19;RPS3A;RPL14;RPL24,KEGG_2021_Human,Ribosome,5.0,****,False
10,prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.6161918944061782,-2.3155854929135526,0.0,0.0,0.0,36/66,19.32%,GNG5;NDUFA4;NDUFS5;NDUFA13;NDUFA3;ND4;NDUFA2;NDUFC2-KCTD14;GNAQ;NDUFA1;NDUFB10;GNAI1;ND1;NDUFB5;MAPK3;NDUFB4;NDUFB8;GNG12;NDUFA7;NDUFS7;MGLL;NDUFS8;NDUFB1;NDUFB3;NDUFB11;GNB2;NDUFB2;NDUFC1;NDUFA8;NDUFA12;ND5;ITPR3;NDUFB7;NDUFA11;ND6;MAPK1,KEGG_2021_Human,Retrograde endocannabinoid signaling,5.0,****,False
18,prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.5076072092978898,-2.041058911593856,0.0,0.0011084303209864198,0.004,42/98,18.64%,NDUFA4;NDUFS5;NDUFA13;ATP6V1G1;ATP5F1E;NDUFA3;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;ATP5F1D;NDUFA1;NDUFB10;ATP6V0C;ATP5ME;ND1;NDUFB5;NDUFB4;NDUFB8;ATP5MC2;ATP5F1C;NDUFA7;NDUFS7;NDUFS8;NDUFB1;NDUFB3;ATP5MG;NDUFB11;NDUFB2;NDUFC1;NDUFA8;NDUFA12;ATP6V1E1;ND5;ATP5PB;COX2;NDUFB7;SDHD;ATP6V1A;NDUFA11;ND6,KEGG_2021_Human,Oxidative phosphorylation,2.955291602650742,**,False
23,prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.46123560181349726,-1.917854802528954,0.0,0.006234920555548611,0.026,45/123,18.64%,NDUFA4;CD36;NDUFS5;CTSD;NDUFA13;ATP5F1E;NDUFA3;RAC1;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;ATP5F1D;MMP2;NDUFA1;NDUFB10;ND1;NDUFB5;NDUFB4;NDUFB8;SLC25A4;ATP5MC2;ATP5F1C;NDUFA7;NDUFS7;NDUFS8;TGFBR2;NDUFB1;NDUFB3;NDUFB11;NDUFB2;NDUFC1;PTEN;NDUFA8;GSK3B;NDUFA12;MPC1;ND5;ATP5PB;COX2;NDUFB7;SDHD;NDUFA11;ND6,KEGG_2021_Human,Diabetic cardiomyopathy,2.205169075867342,**,False
30,prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.48670328813105,-1.8546174106960716,0.0,0.011804782918505369,0.061,29/76,15.74%,NRP1;TJP1;DLC1;SRI;CAV1;NFIB;SYNE1;ATP2B4;RBPMS;PTPRM;ATP2B1;ATRX;PRKAR2B;SIPA1L1;ACVR2A;MGLL;GRK5;TGFBR2;IGF1R;IGFBP5;PRKCE;PTEN;PLPP3;TFPI;ZMIZ1;ADD3;TGFBR3;RXRA;KIT,MSigDB_Hallmark_2020,UV Response Dn,1.9279419948759855,*,False
33,prerank,KEGG_2021_Human__Melanogenesis,-0.5631378487880243,-1.825750690126278,0.0,0.01565657828393318,0.098,18/35,25.86%,CALM2;CALM1;GNAQ;GNAI1;KITLG;MAPK3;FZD6;GNAS;GSK3B;EDNRB;KIT;EP300;MAPK1;CREB1;CAMK2G;HRAS;PRKACA;CTNNB1,KEGG_2021_Human,Melanogenesis,1.8053031461592657,*,False
34,prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.5770404827990755,-1.794138228200528,0.0,0.019951745777755558,0.142,17/29,25.67%,CALM2;CALM1;ATP2B4;GNAQ;GNA11;SCARB1;ATP2B1;GNAS;ATF4;NR4A1;PRKCE;ITPR3;NPR1;CREB1;ATP1A1;CAMK2G;PRKACA,KEGG_2021_Human,Aldosterone synthesis and secretion,1.7000190975474359,*,False
38,prerank,KEGG_2021_Human__Dopaminergic synapse,-0.4880670041504068,-1.757788182632493,0.0,0.02732973510182141,0.208,23/53,25.78%,GNG5;CALM2;CALM1;MAOA;GNAQ;GNAI1;GNG12;GNAS;ATF4;PPP2R5E;GNB2;FOS;GSK3B;PPP3CA;ITPR3;KIF5B;COMT;ARRB2;ARRB1;CREB1;CAMK2G;PRKACA;MAPK14,KEGG_2021_Human,Dopaminergic synapse,1.5633645777612275,*,False
40,prerank,KEGG_2021_Human__Calcium signaling pathway,-0.4891262593388408,-1.7433236683558366,0.0,0.029465772699555658,0.245,21/52,16.46%,KDR;HGF;CALM2;CALM1;ADRB1;ATP2B4;GNAQ;ITPKB;CXCR4;GNA11;TPCN1;ATP2B1;PDGFB;SLC25A4;GNAS;FLT1;TBXA2R;EDNRB;PPP3CA;ITPR3;FLT4,KEGG_2021_Human,Calcium signaling pathway,1.5306821656411855,*,True
41,prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.4782410957799975,-1.737106923408397,0.0017301038062283738,0.029096295925893516,0.267,27/57,25.86%,BMPR2;ID3;TBX3;LIFR;KLF4;MAPK3;FZD6;ACVR2A;IGF1R;ZFHX3;ID4;KAT6A;GSK3B;BMP4;JAK1;ID2;JARID2;AXIN2;MEIS1;MAPK1;APC;SMAD5;PCGF5;GRB2;HRAS;MAPK14;CTNNB1,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1.5361622949087663,*,False
43,prerank,KEGG_2021_Human__Adherens junction,-0.500681897871414,-1.7171659513916133,0.008605851979345954,0.03370635839726885,0.319,18/44,19.32%,TJP1;WASF2;RAC1;PTPRB;PTPRM;AFDN;SORBS1;MAPK3;VCL;TGFBR2;NECTIN3;IGF1R;ACTN4;IQGAP1;WASL;EP300;RHOA;MAPK1,KEGG_2021_Human,Adherens junction,1.4722881657051252,*,False
45,prerank,KEGG_2021_Human__Oocyte meiosis,-0.47047091950617026,-1.6949319894091228,0.0017985611510791368,0.03983421466044946,0.381,25/55,25.78%,CALM2;CALM1;ANAPC13;ANAPC11;PGR;YWHAE;MAPK3;YWHAQ;YWHAB;PPP2R5E;IGF1R;RBX1;CDC26;PPP3CA;SMC3;ITPR3;ANAPC5;MAPK1;PPP3R1;YWHAZ;YWHAG;ANAPC1;CAMK2G;PRKACA;MAPK14,KEGG_2021_Human,Oocyte meiosis,1.399743740617036,*,False
46,prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.4807606048942356,-1.6845030467099464,0.003430531732418525,0.04111850171505392,0.408,21/52,26.38%,CTSD;CALM2;CALM1;HSP90AB1;GNAQ;MMP2;HSP90AA1;HSPA8;GNAI1;PGR;MAPK3;GNAS;ATF4;FOS;ITPR3;MAPK1;CREB1;GRB2;HRAS;PRKACA;EBAG9,KEGG_2021_Human,Estrogen signaling pathway,1.3859627186416565,*,False
47,prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.5134415827883296,-1.6774732530612957,0.00333889816360601,0.041387996449689345,0.436,15/35,21.53%,CALM2;CALM1;INPP5A;DGKZ;ITPKB;CDS2;DGKE;PTEN;PIK3C2A;ITPR3;IMPA1;CDIPT;PIP4K2A;BPNT2;PLCG1,KEGG_2021_Human,Phosphatidylinositol signaling system,1.3831255968392706,*,False
50,prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.5782146413958724,-1.6708586293317,0.0053475935828877,0.04123360794069481,0.457,12/20,25.82%,ATP2B4;GNAQ;ATP2B1;GNAS;CLTC;AP2A2;AP2M1;RAB11A;ATP1A1;AP2S1;PRKACA;AP2B1,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,1.3847486627688443,*,True
52,prerank,KEGG_2021_Human__Coronavirus disease,-0.39294390271896046,-1.6554142031994856,0.0,0.04577470841198605,0.504,50/131,12.59%,NRP1;RPS16;RPS27A;RPL26;RPS29;RPL31;RPL3;FAU;RPS8;RPS15;RPL12;RPL30;RPS20;RPS23;RPS13;RPL35;IFNAR2;RPL27A;RPL13A;RPS18;RPS28;RPL37A;RPL22;RPS25;RPLP2;RPL18;RPS17;RPS19;RPL28;UBA52;RPL7A;RPS21;RPL34;RPL36;MAPK3;RPS7;RPL39;RPL37;RPS4Y2;RPL23A;RPL21;RPL9;RPS24;RPS3;RPL7;FOS;RPL5;RPL36AL;RPL38;RPL23,KEGG_2021_Human,Coronavirus disease,1.3393744135029189,*,True
53,prerank,KEGG_2021_Human__Insulin secretion,-0.6053504672861862,-1.6492736243023716,0.02029520295202952,0.045771652078380395,0.523,10/17,25.67%,GNAQ;GNA11;GNAS;ATF4;ITPR3;VAMP2;CREB1;ATP1A1;CAMK2G;PRKACA,KEGG_2021_Human,Insulin secretion,1.3394034118992106,*,False
55,prerank,KEGG_2021_Human__Circadian entrainment,-0.5470443382768749,-1.643740319881831,0.007259528130671506,0.046230781304475256,0.549,15/26,25.67%,GNG5;CALM2;CALM1;GNAQ;GNAI1;MAPK3;GNG12;GNAS;GNB2;FOS;ITPR3;MAPK1;CREB1;CAMK2G;PRKACA,KEGG_2021_Human,Circadian entrainment,1.3350687668830292,*,False
56,prerank,KEGG_2021_Human__Morphine addiction,-0.559340801344555,-1.6336360162147359,0.018484288354898338,0.049573087645168955,0.585,11/22,25.74%,GNG5;GNAI1;GNG12;GNAS;PDE8B;GRK5;GNB2;ARRB2;ARRB1;PRKACA;GRK2,KEGG_2021_Human,Morphine addiction,1.3047540303484737,*,False
59,prerank,KEGG_2021_Human__Axon guidance,-0.43344301326373114,-1.6268284616550726,0.0050335570469798654,0.05058598877401773,0.609,27/68,20.28%,NRP1;BMPR2;SEMA6A;PLXNA1;SEMA3C;ARHGEF12;CXCL12;SEMA3G;RAC1;DPYSL2;SEMA6D;CXCR4;GNAI1;ROCK1;MAPK3;EPHA4;NTN4;GSK3B;PPP3CA;ITGB1;SRGAP2;RHOA;EFNB2;MAPK1;EPHB4;PPP3R1;PAK4,KEGG_2021_Human,Axon guidance,1.295969756692958,ns,False
61,prerank,KEGG_2021_Human__Thermogenesis,-0.38313450201385846,-1.6196381710547365,0.0,0.05166077031740277,0.635,57/136,27.84%,NDUFA4;NDUFS5;NDUFA13;ATP5F1E;NDUFA3;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;ATP5F1D;NDUFA1;NDUFB10;ATP5ME;ND1;NDUFB5;NDUFB4;NDUFB8;ATP5MC2;ATP5F1C;NDUFA7;TSC2;NDUFS7;GNAS;MGLL;NDUFS8;NDUFB1;NDUFB3;ATP5MG;NDUFB11;NDUFB2;NDUFC1;NDUFA8;NDUFA12;ND5;ATP5PB;NPR1;COX2;NDUFB7;ACSL4;SDHD;NDUFA11;ND6;ARID1A;NDUFA5;CREB1;NDUFV3;GRB2;NDUFAB1;ARID1B;HRAS;PRKACA;MAPK14;NDUFA10;SDHB;SMARCA2;NDUFB6,KEGG_2021_Human,Thermogenesis,1.2868391223186615,ns,False
62,prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.5060697026372821,-1.5880440065379884,0.023985239852398525,0.06616573268342799,0.721,12/27,28.61%,DPM2;ALG2;MAN1C1;RPN2;DAD1;FUT8;RPN1;MAN2A1;GANAB;DPM3;MAN1A2;DPAGT1,KEGG_2021_Human,N-Glycan biosynthesis,1.179366873997802,ns,False
63,prerank,KEGG_2021_Human__Alcoholism,-0.44669479371458287,-1.5843092812588722,0.005434782608695652,0.0653130518485585,0.732,22/51,27.95%,GNG5;CALM2;CALM1;MAOA;HDAC7;GNAI1;MAPK3;GNG12;GNAS;ATF4;SLC29A1;NPY;GNB2;MAPK1;CAMKK2;HDAC5;CREB1;GRB2;HRAS;PRKACA;H2AZ2;FOSB,KEGG_2021_Human,Alcoholism,1.185000022715703,ns,False
65,prerank,KEGG_2021_Human__Cholinergic synapse,-0.48912061159670417,-1.5828106839170746,0.013793103448275862,0.063561551219065,0.741,15/34,25.67%,GNG5;GNAQ;GNAI1;GNA11;MAPK3;GNG12;ATF4;GNB2;FOS;ITPR3;MAPK1;CREB1;CAMK2G;HRAS;PRKACA,KEGG_2021_Human,Cholinergic synapse,1.1968055123825398,ns,False
66,prerank,KEGG_2021_Human__Salivary secretion,-0.5455112255141108,-1.577772572021612,0.01838235294117647,0.06451064468140963,0.759,13/22,27.29%,CALM2;CALM1;ADRB1;ATP2B4;GNAQ;ATP2B1;GNAS;ITPR3;CST5;VAMP2;ATP1A1;PRKACA;SLC12A2,KEGG_2021_Human,Salivary secretion,1.1903686180008535,ns,False
67,prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.4301477990347388,-1.5754514615549493,0.00718132854578097,0.06356421571502892,0.766,29/64,26.88%,CALM2;CALM1;ADRB1;GTF2I;ATP2B4;GNAQ;GNAI1;GNA11;ROCK1;ATP2B1;MAPK3;SLC25A4;PPP1R12A;ATF4;PDE5A;PRKCE;EDNRB;PPP3CA;ITPR3;NPR1;RHOA;MAPK1;PPP3R1;GNA12;CREB1;ATP1A1;BAD;NFATC3;MEF2C,KEGG_2021_Human,cGMP-PKG signaling pathway,1.1967873071685653,ns,False
68,prerank,KEGG_2021_Human__Cell adhesion molecules,-0.5011130390644093,-1.5569780915372822,0.02040816326530612,0.0726021860246105,0.812,11/28,10.75%,CDH5;CD34;CADM1;F11R;VSIR;SDC3;PTPRM;ESAM;PECAM1;NECTIN3;JAM2,KEGG_2021_Human,Cell adhesion molecules,1.139050302658959,ns,False
70,prerank,KEGG_2021_Human__Glutamatergic synapse,-0.4961871241734268,-1.5326274840982537,0.017889087656529516,0.08829835110572176,0.871,15/29,25.74%,GNG5;GNAQ;GNAI1;MAPK3;SHANK3;GNG12;GNAS;GNB2;PPP3CA;ITPR3;MAPK1;PPP3R1;HOMER3;PRKACA;GRK2,KEGG_2021_Human,Glutamatergic synapse,1.0540474064153256,ns,False
72,prerank,KEGG_2021_Human__Cushing syndrome,-0.4178985790509486,-1.526911140726532,0.008944543828264758,0.09001218641113858,0.876,35/57,36.77%,AHR;RAP1A;CCND1;GNAQ;GNAI1;GNA11;SCARB1;MAPK3;FZD6;CDK6;GNAS;ATF4;NR4A1;PDE8B;GSK3B;ITPR3;AXIN2;MAPK1;KMT2A;APC;CREB1;CAMK2G;CDKN1B;PRKACA;CTNNB1;TCF7;CDK4;PBX1;KMT2D;SP1;ATF2;USP8;ASH2L;CDK2;NCEH1,KEGG_2021_Human,Cushing syndrome,1.045698689084783,ns,False
74,prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.5819599093165276,-1.5188666954939682,0.04861111111111111,0.09296959317273595,0.886,8/15,27.61%,LFNG;MFNG;EOGT;OGT;GALNT18;COLGALT1;C1GALT1C1;POFUT2,KEGG_2021_Human,Other types of O-glycan biosynthesis,1.0316590694736933,ns,False
75,prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.5261102004645859,-1.5091857883019737,0.04436229205175601,0.09702340890311774,0.903,9/20,25.77%,ALG2;MAN1C1;RPN2;DAD1;FUT8;RPN1;MAN2A1;HEXB;MAN1A2,KEGG_2021_Human,Various types of N-glycan biosynthesis,1.0131234705695196,ns,False
77,prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.5113004130693701,-1.4755544032892975,0.05565529622980251,0.12438666508319479,0.951,11/21,29.41%,GNAQ;GNAS;GPX1;ATF4;CANX;ITPR3;CREB1;ATP1A1;GPX7;PRKACA;PDIA4,KEGG_2021_Human,Thyroid hormone synthesis,0.9052261758445748,ns,False
81,prerank,KEGG_2021_Human__Long-term potentiation,-0.45614653030743707,-1.4514283221962148,0.04576271186440678,0.14472573168334046,0.968,14/29,25.67%,CALM2;CALM1;RAP1A;GNAQ;MAPK3;ATF4;PPP3CA;ITPR3;EP300;MAPK1;PPP3R1;CAMK2G;HRAS;PRKACA,KEGG_2021_Human,Long-term potentiation,0.8394542461126254,ns,False
83,prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.41483718432780603,-1.4422377570243017,0.04285714285714286,0.15112958413272926,0.978,18/45,19.32%,CALCRL;CALM2;CALM1;ARHGEF12;CALD1;MYL6;GNAQ;GNA11;ROCK1;RAMP3;MAPK3;PPP1R12A;GNAS;PRKCE;ITPR3;NPR1;RHOA;MAPK1,KEGG_2021_Human,Vascular smooth muscle contraction,0.8206505127094716,ns,False
84,prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.36544587421147007,-1.4409511247207862,0.012658227848101266,0.14856924980935834,0.978,33/98,17.15%,NDUFA4;NDUFS5;NDUFA13;NDUFA3;RAC1;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;NDUFA1;NDUFB10;NDUFB5;NDUFB4;NDUFB8;NDUFA7;NDUFS7;ATF4;MAP3K11;NDUFS8;NDUFB1;NDUFB3;NDUFB11;NDUFB2;FOS;NDUFC1;NDUFA8;GSK3B;NDUFA12;RXRA;LEPR;COX2;NDUFB7;SDHD,KEGG_2021_Human,Non-alcoholic fatty liver disease,0.8280710695798787,ns,False
85,prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.4359134368665325,-1.439554127166724,0.06942148760330578,0.146197340878438,0.978,24/37,42.14%,ANAPC13;ANAPC11;HSP90AB1;HSP90AA1;GNAI1;PGR;MAPK3;IGF1R;CDC26;ANAPC5;MAPK1;ANAPC1;PRKACA;MAPK14;RPS6KA3;CPEB2;CDK2;FZR1;ANAPC4;KRAS;GNAI2;ANAPC2;PRKACB;MAPK12,KEGG_2021_Human,Progesterone-mediated oocyte maturation,0.835060526504858,ns,False
86,prerank,KEGG_2021_Human__GnRH signaling pathway,-0.44001311869420595,-1.4374187947741324,0.041666666666666664,0.1443805387025419,0.979,19/36,33.69%,CALM2;CALM1;GNAQ;MMP2;GNA11;MAPK3;GNAS;ATF4;ITPR3;MAPK1;GRB2;CAMK2G;HRAS;PRKACA;MAPK14;MAP3K2;JUN;PLD2;CDC42,KEGG_2021_Human,GnRH signaling pathway,0.8404913421105376,ns,False
87,prerank,KEGG_2021_Human__Amphetamine addiction,-0.477372820007825,-1.4356523091415379,0.05027932960893855,0.1422874501518883,0.979,15/25,34.59%,CALM2;CALM1;MAOA;GNAS;ATF4;FOS;PPP3CA;PPP3R1;CREB1;CAMK2G;PRKACA;FOSB;JUN;ATF2;HDAC2,KEGG_2021_Human,Amphetamine addiction,0.8468334032898404,ns,False
90,prerank,KEGG_2021_Human__Cholesterol metabolism,-0.5060537516962451,-1.4285375745602167,0.05892857142857143,0.14637675027334124,0.985,10/20,26.80%,CD36;SCARB1;NPC2;VAPA;LPL;LDLRAP1;APOE;TSPO;LIPA;VAPB,KEGG_2021_Human,Cholesterol metabolism,0.8345278988913357,ns,False
93,prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.39697312545929064,-1.4191339203355302,0.043782837127845885,0.15263085519983,0.986,11/51,9.70%,CALM2;CALM1;ADRB1;ATP2B4;GNAQ;GNAI1;ATP2B1;MAPK3;GNAS;ATF4;PPP2R5E,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,0.8163576623938182,ns,False
94,prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.36414272806892856,-1.4136421973800022,0.03046594982078853,0.15549790484716194,0.987,28/86,19.32%,KDR;HGF;TEK;CALM2;CALM1;RALA;RASGRP3;RAC1;RAP1A;GNAQ;AFDN;GNAI1;KITLG;MAPK3;PDGFB;SIPA1L1;GNAS;FLT1;MAGI3;P2RY1;IGF1R;RAPGEF5;RAPGEF2;KIT;FLT4;ITGB1;RHOA;MAPK1,KEGG_2021_Human,Rap1 signaling pathway,0.8082754582091456,ns,False
95,prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.3266139534967303,-1.4115417826342975,0.01607142857142857,0.15375512023968765,0.989,57/160,27.84%,NDUFA4;ATP6V1G1;ATP5F1E;NDUFA3;NDUFA2;ATP5F1D;NDUFA1;MGST3;ATP6V0C;ATP5ME;NDUFB5;IDH2;NDUFB4;NDUFB8;SLC25A4;ATP5MC2;MRPL34;ATP5F1C;NDUFA7;NDUFS7;OGDH;POLR2F;LDHB;NDUFS8;NDUFB1;NDUFB3;ATP5MG;NDUFB2;NDUFC1;NDUFA8;ATP6V1E1;MPC1;ATP5PB;MDH1;TIMM13;ETFB;NDUFB7;SDHD;NNT;ACADM;ACAT1;SLC25A11;ECH1;NDUFA5;ECHS1;ATP6V0B;ISCU;MRPL15;MRPS11;NDUFAB1;GPX4;TOMM22;SUCLG1;MRPL11;ATP6AP1;SDHB;NDUFB6,MSigDB_Hallmark_2020,Oxidative Phosphorylation,0.8131704127569939,ns,False
96,prerank,KEGG_2021_Human__RNA polymerase,-0.5142103462796455,-1.4011052216032134,0.0798611111111111,0.16090928305063903,0.994,8/17,27.42%,POLR2L;POLR2K;POLR2F;POLR2J3;POLR1F;POLR2I;POLR2B;POLR2C,KEGG_2021_Human,RNA polymerase,0.79341890020568,ns,False
97,prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.3684328771544614,-1.4000350738824519,0.026041666666666668,0.15844255690554743,0.994,20/74,14.77%,CDH5;KDR;BMPR2;THBD;CALM2;CALM1;TXN;CAV1;HSP90AB1;RAC1;MMP2;MGST3;HSP90AA1;PECAM1;PDGFB;ACVR2A;NFE2L2;FOS;BMP4;GSTM3,KEGG_2021_Human,Fluid shear stress and atherosclerosis,0.8001281576776799,ns,False
98,prerank,KEGG_2021_Human__Synaptic vesicle cycle,-0.4449547547113801,-1.3958701011789472,0.07958477508650519,0.15931838480311472,0.994,15/28,25.82%,ATP6V1G1;SLC6A4;ATP6V0C;CLTC;ATP6V1E1;AP2A2;AP2M1;ATP6V1A;UNC13B;STXBP1;VAMP2;ATP6V0B;ATP6V0A1;AP2S1;AP2B1,KEGG_2021_Human,Synaptic vesicle cycle,0.797734105191722,ns,False
99,prerank,KEGG_2021_Human__Cortisol synthesis and secretion,-0.4834594299015531,-1.3958020297122555,0.08363636363636363,0.15598144728968133,0.994,16/21,41.21%,GNAQ;GNA11;SCARB1;GNAS;ATF4;NR4A1;PDE8B;ITPR3;CREB1;PRKACA;PBX1;SP1;ATF2;NCEH1;PLCB3;PRKACB,KEGG_2021_Human,Cortisol synthesis and secretion,0.8069270543306275,ns,False
101,prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.4465378086093341,-1.3801292751255807,0.08765652951699464,0.17059803903054285,0.996,12/27,15.58%,APLNR;CALCRL;ADRB1;APLN;THRA;NPW;S1PR4;P2RY1;TBXA2R;NPY;EDNRB;LEPR,KEGG_2021_Human,Neuroactive ligand-receptor interaction,0.768025965214856,ns,False
102,prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3356389665390317,-1.3733422784837956,0.023423423423423424,0.17447386021276864,0.996,55/113,34.35%,MARCKS;RALBP1;ARHGEF12;ARHGAP29;MID1IP1;WASF2;EPB41L2;ROCK1;YWHAE;KIF1B;PREX1;VCL;MAP3K11;ABI1;SPTBN1;NF1;ACTN4;ARHGEF7;RAPGEF5;SMC3;WASL;KIF5B;DST;ARHGAP5;CDC42BPA;APC;TRIO;MYO1E;ARHGEF3;ARAP3;PCGF5;RASA1;NUMA1;SMC4;CKAP5;NIN;RABGAP1;RFC1;GSN;ALS2;KIFAP3;HOOK3;SPTAN1;ARHGAP27;TUBGCP5;CDC42EP1;RASAL2;SUN2;CAPZB;PCM1;TBCD;DLG1;CDC42;EPB41;NCK2,MSigDB_Hallmark_2020,Mitotic Spindle,0.7582696301129367,ns,False
103,prerank,KEGG_2021_Human__Renin secretion,-0.4418765955478834,-1.367196302537964,0.0812274368231047,0.1777164430459094,0.997,13/27,25.67%,CALM2;CALM1;ADRB1;GNAQ;GNAI1;GNAS;AQP1;PPP3CA;ITPR3;NPR1;PPP3R1;CREB1;PRKACA,KEGG_2021_Human,Renin secretion,0.7502723876492227,ns,False
104,prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.4037698736639136,-1.366716235772052,0.06713780918727916,0.17477729301313863,0.997,19/41,27.82%,BMPR2;ID3;ROCK1;MAPK3;SMAD6;ACVR2A;TGFBR2;RBX1;ID4;BMP4;ID2;EP300;RHOA;MAPK1;SMAD5;BAMBI;TGFB1;ZFYVE9;ZFYVE16,KEGG_2021_Human,TGF-beta signaling pathway,0.7575149913793552,ns,True
105,prerank,KEGG_2021_Human__Long-term depression,-0.4570555464632925,-1.3548819552655844,0.10387323943661972,0.18600438812905937,0.997,10/23,25.60%,GNAQ;GNAI1;GNA11;MAPK3;GNAS;IGF1R;ITPR3;MAPK1;GNA12;HRAS,KEGG_2021_Human,Long-term depression,0.7304768099876938,ns,False
106,prerank,KEGG_2021_Human__Serotonergic synapse,-0.43348192921692674,-1.353299529085567,0.09352517985611511,0.18469753122628998,0.997,10/30,15.25%,GNG5;MAOA;SLC6A4;GNAQ;GNAI1;MAPK3;GNG12;GNAS;GNB2;ITPR3,KEGG_2021_Human,Serotonergic synapse,0.7335389095514475,ns,False
107,prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.3553849670592159,-1.3526828038566587,0.061224489795918366,0.18187145620524817,0.997,24/70,18.63%,EMP2;TSPAN13;SGK1;CAV1;CXCL12;ATP2B4;CCND1;KLF4;SCARB1;PGR;IDH2;CD9;PRKAR2B;SLC29A1;FOS;CKB;CPE;ADD3;JAK1;ID2;ETFB;SERPINA1;UNC13B;PDCD4,MSigDB_Hallmark_2020,Estrogen Response Late,0.7402354558858247,ns,False
109,prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.3791176213384736,-1.349258476120327,0.07719928186714542,0.18278323890377446,0.997,24/52,26.88%,CALM2;CALM1;MYL6;CCND1;GNAQ;GNAI1;ROCK1;MAPK3;PPP1R12A;GNAS;EEF2;FOS;PPP3CA;ITPR3;NPR1;RHOA;MAPK1;CAMKK2;PPP3R1;CAMK2G;HRAS;PRKACA;NFATC3;MEF2C,KEGG_2021_Human,Oxytocin signaling pathway,0.738063631279115,ns,False
112,prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.4060038336817745,-1.3142069077374776,0.10307414104882459,0.22551518712432794,0.999,16/32,27.29%,TJP1;ATP6V1G1;SEC61G;ATP6V0C;ARF1;TJP2;GNAS;SEC61B;ATP6V1E1;ATP6V1A;PLCG1;ATP6V0B;ATP6V0A1;PRKACA;ATP6AP1;SLC12A2,KEGG_2021_Human,Vibrio cholerae infection,0.6468242056166357,ns,True
116,prerank,KEGG_2021_Human__Ras signaling pathway,-0.3252506411285718,-1.2997581760321906,0.0547945205479452,0.24420105509232057,1.0,23/93,11.79%,KDR;HGF;GNG5;TEK;CALM2;CALM1;RALA;RASGRP3;RALBP1;RAC1;RAP1A;ETS1;AFDN;ETS2;KITLG;STK4;MAPK3;PDGFB;GNG12;FLT1;RASA4B;IGF1R;GNB2,KEGG_2021_Human,Ras signaling pathway,0.6122524639792493,ns,False
117,prerank,KEGG_2021_Human__Apelin signaling pathway,-0.35681269966199664,-1.2992819707507763,0.08849557522123894,0.24066064113943303,1.0,12/62,12.15%,APLNR;GNG5;CALM2;CALM1;APLN;CCND1;GNAQ;GNAI1;MAPK3;GNG12;GNB2;PRKCE,KEGG_2021_Human,Apelin signaling pathway,0.618594930637506,ns,False
122,prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.42481935418856975,-1.2858983784176818,0.15357766143106458,0.25696472579281726,1.0,11/25,27.98%,CALM2;CALM1;GNAQ;GNAS;PRKCE;ITPR3;PLCG1;CAMK2G;PRKACA;MAPK14;PRKCH,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,0.5901264892949744,ns,True
126,prerank,KEGG_2021_Human__Protein export,-0.4521126715235407,-1.2724503880487417,0.18047882136279927,0.2741251512049677,1.0,6/19,14.19%,SEC61G;SEC62;SPCS1;SRP14;SEC61B;SPCS2,KEGG_2021_Human,Protein export,0.5620511157614247,ns,False
128,prerank,KEGG_2021_Human__GnRH secretion,-0.4678960923419915,-1.2693978204298848,0.17736486486486486,0.2746690335404348,1.0,7/17,19.62%,GNAQ;GNA11;MAPK3;ITPR3;MAPK1;ARRB2;ARRB1,KEGG_2021_Human,GnRH secretion,0.5611903006106973,ns,False
129,prerank,KEGG_2021_Human__Cocaine addiction,-0.4626380255481847,-1.2671303750866,0.15630550621669628,0.2738458877446858,1.0,10/17,33.62%,MAOA;GNAI1;GNAS;ATF4;CREB1;PRKACA;FOSB;CDK5;JUN;ATF2,KEGG_2021_Human,Cocaine addiction,0.5624937763462985,ns,False
131,prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.3426861107870579,-1.2356420616240735,0.14690265486725665,0.3233040955599744,1.0,22/58,25.78%,GNG5;COL4A2;COL4A1;MMP2;GNAI1;MAPK3;GNG12;GNAS;ATF4;TGFBR2;GNB2;FOS;EDNRB;MAPK1;ARRB2;ARRB1;CREB1;TGFB1;GRB2;HRAS;PRKACA;MAPK14,KEGG_2021_Human,Relaxin signaling pathway,0.49038879378673916,ns,False
132,prerank,KEGG_2021_Human__Parkinson disease,-0.2856126911359236,-1.2344885725860926,0.06776556776556776,0.3202176023735411,1.0,51/175,17.42%,NDUFA4;RPS27A;NDUFS5;CALM2;CALM1;NDUFA13;TXN;MAOA;ATP5F1E;NDUFA3;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;ATP5F1D;NDUFA1;NDUFB10;PARK7;UBA52;GNAI1;ND1;NDUFB5;NDUFB4;NDUFB8;SLC25A4;ATP5MC2;ATP5F1C;NDUFA7;NDUFS7;GNAS;ATF4;NDUFS8;TUBB2A;NDUFB1;NDUFB3;NFE2L2;NDUFB11;NDUFB2;NDUFC1;NDUFA8;NDUFA12;ND5;ATP5PB;ITPR3;PSMB5;LRRK2;COX2;NDUFB7;SDHD;KIF5B,KEGG_2021_Human,Parkinson disease,0.49455479857667817,ns,False
135,prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.33776358731213674,-1.221806341315552,0.1549053356282272,0.339309572400085,1.0,14/56,10.75%,CDH5;CXCL12;RAC1;F11R;RAP1A;MMP2;ESAM;AFDN;CXCR4;GNAI1;ROCK1;PECAM1;VCL;JAM2,KEGG_2021_Human,Leukocyte transendothelial migration,0.4694038881241303,ns,False
138,prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.42132322579110026,-1.2204985450559769,0.1733800350262697,0.33642991838708963,1.0,11/21,30.45%,B4GALT6;PLPP3;ASAH1;PLPP1;UGCG;SPHK2;ACER2;GLA;CERK;KDSR;ARSA,KEGG_2021_Human,Sphingolipid metabolism,0.4731053897687196,ns,False
139,prerank,KEGG_2021_Human__Prion disease,-0.28177091054309816,-1.2199539370479362,0.10477941176470588,0.3323401593093941,1.0,54/173,20.48%,NDUFA4;NDUFS5;NDUFA13;CAV1;ATP5F1E;NDUFA3;RAC1;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;ATP5F1D;NDUFA1;NDUFB10;HSPA8;ND1;NDUFB5;MAPK3;NDUFB4;NDUFB8;SLC25A4;ATP5MC2;ATP5F1C;NDUFA7;NDUFS7;ATF4;NDUFS8;TUBB2A;NDUFB1;NDUFB3;NOTCH1;NDUFB11;NDUFB2;NDUFC1;NDUFA8;GSK3B;NDUFA12;ND5;PPP3CA;ATP5PB;ITPR3;PSMB5;SOD1;COX2;NDUFB7;SDHD;KIF5B;NDUFA11;ND6;MAPK1;PSMD1;PPP3R1;CYBA,KEGG_2021_Human,Prion disease,0.4784171762877681,ns,False
140,prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.4147869105551195,-1.2198600117280118,0.18848167539267016,0.32759079105988936,1.0,12/23,38.67%,IDH2;OGDH;MDH1;SDHD;SUCLG1;SDHB;SUCLG2;ACLY;SDHA;IDH3G;MDH2;IDH1,KEGG_2021_Human,Citrate cycle (TCA cycle),0.48466831523911413,ns,False
145,prerank,KEGG_2021_Human__Huntington disease,-0.27486399677301343,-1.2083190919791122,0.09236234458259325,0.34283505321421504,1.0,52/190,18.64%,NDUFA4;NDUFS5;NDUFA13;ATP5F1E;NDUFA3;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;POLR2L;ATP5F1D;GNAQ;NDUFA1;NDUFB10;POLR2K;ND1;NDUFB5;NDUFB4;NDUFB8;SLC25A4;ATP5MC2;ATP5F1C;NDUFA7;NDUFS7;CLTC;GPX1;POLR2F;NDUFS8;TUBB2A;NDUFB1;NDUFB3;NDUFB11;NDUFB2;RCOR1;NDUFC1;NDUFA8;NDUFA12;POLR2J3;ND5;ATP5PB;PSMB5;AP2A2;AP2M1;SOD1;COX2;NDUFB7;SDHD;KIF5B;EP300;NDUFA11;ND6,KEGG_2021_Human,Huntington disease,0.4649147799833205,ns,False
147,prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.2905650164339698,-1.204334072928311,0.125,0.34520375605329234,1.0,36/131,16.46%,KDR;HGF;GNG5;TEK;SGK1;COL4A2;HSP90AB1;IFNAR2;RAC1;ITGA1;COL4A1;CCND1;HSP90AA1;KITLG;YWHAE;MAPK3;PDGFB;GNG12;TSC2;CDK6;YWHAQ;YWHAB;ATF4;NR4A1;PPP2R5E;FLT1;IGF1R;GNB2;PTEN;ITGA2;GSK3B;ITGB5;JAK1;RXRA;KIT;FLT4,KEGG_2021_Human,PI3K-Akt signaling pathway,0.461924487509713,ns,False
148,prerank,KEGG_2021_Human__cAMP signaling pathway,-0.3208068531786052,-1.193349364901425,0.1931407942238267,0.3600933831710275,1.0,25/65,26.35%,CALM2;CALM1;ADRB1;ATP2B4;RAC1;RAP1A;AFDN;GNAI1;ROCK1;ATP2B1;MAPK3;PPP1R12A;GNAS;NPY;FOS;NPR1;EP300;RHOA;MAPK1;ARAP3;CREB1;ATP1A1;CAMK2G;PRKACA;BAD,KEGG_2021_Human,cAMP signaling pathway,0.4435848588528536,ns,False
149,prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.3808948250058008,-1.1846436828649602,0.22122302158273383,0.3715193037137228,1.0,11/27,29.10%,DYNLL1;GNAS;DYNC1I2;ARHGDIB;RAB11A;DYNC1LI2;VAMP2;CREB1;PRKACA;RAB11B;RAB5B,KEGG_2021_Human,Vasopressin-regulated water reabsorption,0.43001861587770496,ns,False
150,prerank,KEGG_2021_Human__GABAergic synapse,-0.41237516363064436,-1.182627071091788,0.24113475177304963,0.37020418106028724,1.0,5/21,12.37%,GNG5;GNAI1;GNG12;GNB2;TRAK2,KEGG_2021_Human,GABAergic synapse,0.4315586806637268,ns,False
151,prerank,KEGG_2021_Human__Gap junction,-0.36255778658173565,-1.1806047185690662,0.23793103448275862,0.3689364771472298,1.0,9/34,10.45%,TJP1;ADRB1;GNAQ;GNAI1;GNA11;MAPK3;PDGFB;GNAS;TUBB2A,KEGG_2021_Human,Gap junction,0.43304840348671625,ns,False
152,prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.2943300973541953,-1.1797086571227204,0.16220735785953178,0.36565843092351663,1.0,29/95,21.48%,TMSB4Y;ARHGEF12;CXCL12;RDX;WASF2;RAC1;ITGA1;CXCR4;ROCK1;MAPK3;PDGFB;GNG12;PPP1R12A;VCL;ARPC2;ITGA2;ITGB5;ACTN4;ARHGEF7;IQGAP1;BRK1;ITGB1;WASL;RHOA;PIP4K2A;MAPK1;PAK4;APC;DOCK1,KEGG_2021_Human,Regulation of actin cytoskeleton,0.43692440867116,ns,False
153,prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.32753336808395866,-1.1785485896975643,0.2136602451838879,0.36318827897441025,1.0,27/50,33.62%,MMP15;GATA3;GNAQ;GNAI1;GNA11;MAPK3;GNAS;ATF4;FOS;ITPR3;RXRA;RHOA;MAPK1;ARRB2;ARRB1;GNA12;CREB1;PRKACA;MAFB;MEF2C;LRP5;LRP6;MEF2A;BCL2;SP1;PLD2;ATF2,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",0.43986817573155496,ns,False
156,prerank,KEGG_2021_Human__Pancreatic secretion,-0.38610292251098427,-1.1658135068057545,0.25220458553791886,0.3823647069118548,1.0,9/24,18.49%,ATP2B4;RAC1;RAP1A;GNAQ;ATP2B1;GNAS;ITPR3;RAB11A;RHOA,KEGG_2021_Human,Pancreatic secretion,0.4175222008645411,ns,False
162,prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.30021467934143975,-1.1399818473746437,0.23022847100175747,0.42755900232179406,1.0,27/75,26.35%,CYP1A1;AHR;ADRB1;HSP90AB1;CCND1;MGST3;HSP90AA1;GNAI1;KLF4;PGR;MAPK3;GNAS;ATF4;GSTK1;FOS;GSTM3;RXRA;MAPK1;ARRB2;ARRB1;CREB1;GRB2;PTGES3;KPNB1;HRAS;PRKACA;BAD,KEGG_2021_Human,Chemical carcinogenesis,0.3690039449951408,ns,False
163,prerank,KEGG_2021_Human__VEGF signaling pathway,-0.3585227282787669,-1.1237413617074903,0.29772329246935203,0.456524080472426,1.0,11/30,26.35%,KDR;RAC1;MAPK3;PPP3CA;MAPK1;PPP3R1;PLCG1;SPHK2;HRAS;MAPK14;BAD,KEGG_2021_Human,VEGF signaling pathway,0.34053630960728437,ns,False
165,prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.3276129029013945,-1.1217145362971648,0.2885304659498208,0.4549966160013685,1.0,16/44,25.60%,DGKZ;WASF2;RAC1;MAPK3;PDGFB;TSC2;SLC44A2;DGKE;FOS;PLPP3;GPCPD1;PLPP1;MAPK1;PLCG1;GRB2;HRAS,KEGG_2021_Human,Choline metabolism in cancer,0.3419918333591461,ns,False
166,prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.36495786141772985,-1.1201196904050703,0.3076923076923077,0.4524681847161627,1.0,8/27,21.53%,INPP5A;ITPKB;PTEN;PIK3C2A;IMPA1;CDIPT;PIP4K2A;PLCG1,KEGG_2021_Human,Inositol phosphate metabolism,0.3444119527857997,ns,False
167,prerank,KEGG_2021_Human__Endocytosis,-0.26333406685862515,-1.1198846262364834,0.21869488536155202,0.44733374046772306,1.0,66/143,38.40%,ARAP2;CAV1;SNX3;CXCR4;HSPA8;ARF1;CLTC;ARPC2;GRK5;TGFBR2;IGF1R;VPS36;CHMP2A;EHD3;NEDD4;VPS4B;EHD4;AP2A2;AP2M1;LDLRAP1;RAB11A;CAPZA1;WASL;KIF5B;RHOA;CHMP4B;ARRB2;ARRB1;RAB22A;EHD2;ASAP2;WASHC4;ARAP3;CHMP2B;EPN2;WASHC3;AP2S1;HRAS;GRK2;AP2B1;ZFYVE9;SH3GL1;ZFYVE16;RAB11B;RAB5B;EPS15;PIP5K1C;ARAP1;CAPZB;SNX2;PLD2;GBF1;CDC42;VPS25;USP8;ARPC3;CYTH3;IQSEC2;ARF5;IQSEC1;CAPZA2;SH3GLB2;RUFY1;CLTA;WASHC1;ARFGAP3,KEGG_2021_Human,Endocytosis,0.3493683436196138,ns,False
168,prerank,KEGG_2021_Human__Malaria,-0.41556711327781565,-1.1180808660804675,0.31022530329289427,0.44573092218739874,1.0,4/16,6.97%,HGF;CD36;CD81;PECAM1,KEGG_2021_Human,Malaria,0.35092723607419885,ns,False
169,prerank,KEGG_2021_Human__Wnt signaling pathway,-0.3037980059768222,-1.1129397579267801,0.2888086642599278,0.45083733983350044,1.0,26/61,30.67%,PRICKLE1;RAC1;DAAM1;CCND1;FZD6;RBX1;CTNNBIP1;GSK3B;CSNK1A1L;PRICKLE2;PPP3CA;EP300;SOX17;AXIN2;RHOA;PPP3R1;APC;BAMBI;CSNK2A1;CAMK2G;PRKACA;CTNNB1;NFATC3;LRP5;TCF7;LRP6,KEGG_2021_Human,Wnt signaling pathway,0.34598012143676826,ns,False
170,prerank,KEGG_2021_Human__Alzheimer disease,-0.2500409806137467,-1.1093847279187952,0.21908127208480566,0.45304120360531547,1.0,60/211,20.95%,NDUFA4;NDUFS5;CALM2;CALM1;NDUFA13;ATP5F1E;NDUFA3;ND4;CYTB;COX1;NDUFA2;NDUFC2-KCTD14;ATP5F1D;GNAQ;NDUFA1;NDUFB10;ND1;NDUFB5;PSENEN;MAPK3;NDUFB4;NDUFB8;FZD6;SLC25A4;ATP5MC2;ATP5F1C;NDUFA7;NDUFS7;ATF4;NDUFS8;TUBB2A;NDUFB1;NDUFB3;NDUFB11;NDUFB2;NDUFC1;LPL;NDUFA8;GSK3B;NDUFA12;CSNK1A1L;ND5;PPP3CA;ATP5PB;ITPR3;PSMB5;ADAM10;COX2;NDUFB7;SDHD;KIF5B;AXIN2;NDUFA11;ND6;MAPK1;CAPN2;PSMD1;PPP3R1;APOE;APC,KEGG_2021_Human,Alzheimer disease,0.3438622975795395,ns,False
173,prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.26104948677451845,-1.0910380653131213,0.2670250896057348,0.48761479864782287,1.0,46/130,27.35%,LTC4S;CAVIN2;CAVIN1;CD36;APLP2;SPARCL1;COL15A1;LIFR;COL4A1;MGST3;SCARB1;SORBS1;TALDO1;SCP2;MTARC2;MGLL;CD151;GPD2;MAP4K3;LPL;UBQLN1;CMPK1;CCNG2;QDPR;ETFB;SOD1;NDUFB7;PDCD4;APOE;HSPB8;RREB1;ACADM;SAMM50;ECH1;NDUFA5;G3BP2;ECHS1;YWHAG;MRPL15;RIOK3;NDUFAB1;GPX4;AGPAT3;SUCLG1;DNAJC15;SDHB,MSigDB_Hallmark_2020,Adipogenesis,0.31192312242699066,ns,False
175,prerank,KEGG_2021_Human__Platelet activation,-0.30336831713239054,-1.0836419131457147,0.3373083475298126,0.4982813176385492,1.0,21/56,25.78%,ARHGEF12;VAMP8;RAP1A;GNAQ;GNAI1;ROCK1;MAPK3;PPP1R12A;GNAS;P2RY1;TBXA2R;ITGA2;ITPR3;ITGB1;TBXAS1;RHOA;MAPK1;SNAP23;VWF;PRKACA;MAPK14,KEGG_2021_Human,Platelet activation,0.30252539578818455,ns,False
176,prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.31438495822981355,-1.0812482965636587,0.34797891036906853,0.4980196543059587,1.0,10/42,15.44%,TJP1;BMPR2;ID3;WWTR1;SMAD6;HIPK2;UBE2D3;SPTBN1;KLF10;ID2,MSigDB_Hallmark_2020,TGF-beta Signaling,0.3027535175049616,ns,True
177,prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.3958401341696623,-1.079301357016987,0.3464163822525597,0.4968098060853052,1.0,7/17,19.62%,LFNG;CCND1;PSENEN;NOTCH1;RBX1;HES1;ARRB1,MSigDB_Hallmark_2020,Notch Signaling,0.30380984059575317,ns,False
180,prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.2804397385058759,-1.0742628703416248,0.3185689948892675,0.5022403645712258,1.0,27/79,21.53%,STMN1;BMPR2;VIM;MARCKS;FOXP1;SOX4;RDX;SPRY2;CCND1;ROCK1;MAPK3;PDGFB;CDK6;NOTCH1;PRKCE;PTEN;ZEB1;CCNG1;ATM;EP300;RHOA;PDCD4;MAPK1;PAK4;APC;HDAC5;PLCG1,KEGG_2021_Human,MicroRNAs in cancer,0.299088386393925,ns,False
182,prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.27965086465785527,-1.0695180400920319,0.33217391304347826,0.5070791610932623,1.0,40/70,41.78%,RAB2A;ARF1;KIF1B;VAMP3;GNAS;CLTC;VPS4B;AP2M1;SOD1;ADAM10;LMAN1;MAPK1;DST;RAB22A;SNAP23;COPB1;ATP1A1;AP2S1;AP2B1;ATP7A;ERGIC3;GLA;RPS6KA3;CLN5;PPT1;VAMP7;SNX2;GBF1;SCAMP1;GOLGA4;STX16;AP1G1;CLTA;ARFGAP3;RER1;PAM;AP3B1;MON2;COG2;CLCN3,MSigDB_Hallmark_2020,Protein Secretion,0.2949242368356139,ns,False
183,prerank,KEGG_2021_Human__Hedgehog signaling pathway,-0.37515589561037693,-1.0665985894846768,0.39317773788150806,0.5076641321500246,1.0,12/21,35.62%,CCND1;GSK3B;CSNK1A1L;ARRB2;ARRB1;PRKACA;GRK2;CUL3;MOSMO;CSNK1G2;BCL2;SPOPL,KEGG_2021_Human,Hedgehog signaling pathway,0.2944235195963703,ns,False
186,prerank,KEGG_2021_Human__Renal cell carcinoma,-0.3109267329265854,-1.060909307593439,0.351493848857645,0.5144532347667378,1.0,17/44,26.35%,HGF;RAC1;EPAS1;RAP1A;ETS1;MAPK3;PDGFB;RBX1;ELOB;EP300;MAPK1;PAK4;ELOC;TGFB1;GRB2;HRAS;BAD,KEGG_2021_Human,Renal cell carcinoma,0.2886540976864564,ns,False
188,prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.29846873937280416,-1.0577401386336767,0.3415929203539823,0.5156167562511182,1.0,11/44,21.48%,CAV1;WASF2;RAC1;CLTC;VCL;ARPC2;ELMO1;ITGB1;WASL;RHOA;DOCK1,KEGG_2021_Human,Bacterial invasion of epithelial cells,0.28767297760809885,ns,False
189,prerank,MSigDB_Hallmark_2020__Apical Junction,-0.27296217249810106,-1.0576263553582965,0.3568965517241379,0.5103348803658618,1.0,30/81,25.78%,TJP1;CD34;PCDH1;EPB41L2;SDC3;MMP2;GNAI1;SIRPA;PECAM1;MAP4K2;VCL;ARPC2;NECTIN3;RSU1;PTEN;ITGA2;NF1;ICAM2;ACTN4;LDLRAP1;ITGB1;WASL;JUP;PLCG1;SKAP2;PKD1;RASA1;VWF;HRAS;MAPK14,MSigDB_Hallmark_2020,Apical Junction,0.2921447474962438,ns,False
190,prerank,KEGG_2021_Human__Viral myocarditis,-0.38044854821939567,-1.0520810619786456,0.3924268502581756,0.5168027202380209,1.0,5/18,7.96%,CAV1;RAC1;CCND1;EIF4G2;EIF4G3,KEGG_2021_Human,Viral myocarditis,0.2866752090585359,ns,False
192,prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.3016008756417043,-1.038746378397393,0.4063047285464098,0.5411478061622059,1.0,14/45,22.22%,MARCKS;WASF2;RAC1;MAPK3;ARPC2;PRKCE;MYO10;PLPP3;PLPP1;MAPK1;DOCK1;PLCG1;ASAP2;SPHK2,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,0.26668409786312663,ns,False
194,prerank,KEGG_2021_Human__Gastric acid secretion,-0.35714825475173456,-1.031899768185125,0.425531914893617,0.5507470305713605,1.0,5/22,8.90%,CALM2;CALM1;GNAQ;GNAI1;GNAS,KEGG_2021_Human,Gastric acid secretion,0.2590478357295308,ns,False
204,prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3086483716878617,-0.9981642371037192,0.44932432432432434,0.6223129345246281,1.0,9/35,15.94%,HSD3B7;HSD17B11;IDH2;SCP2;GSTK1;SLC29A1;NEDD4;RXRA;SOD1,MSigDB_Hallmark_2020,Bile Acid Metabolism,0.205991172285184,ns,False
206,prerank,KEGG_2021_Human__Nucleotide excision repair,-0.3329601582215722,-0.992485942217292,0.46206896551724136,0.6291181791538072,1.0,10/23,30.57%,CETN2;GTF2H5;RBX1;PCNA;XPC;RAD23B;POLD4;RFC1;DDB1;RPA3,KEGG_2021_Human,Nucleotide excision repair,0.20126776515339212,ns,False
207,prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.2831862532213442,-0.9897534833281736,0.46619217081850534,0.6293196279674472,1.0,18/52,25.61%,SEMA3C;CADM1;HSD3B7;HSD17B11;IDH2;SLC25A4;SCP2;GSTK1;SCGB1A1;VPS4B;PRDX1;SOD1;ACSL4;TSPO;ECH1;FIS1;HRAS;FDPS,MSigDB_Hallmark_2020,Pperoxisome,0.201128722749545,ns,False
208,prerank,KEGG_2021_Human__ECM-receptor interaction,-0.34147953447000107,-0.9886045771289013,0.47237076648841353,0.6259777928588554,1.0,7/22,17.36%,CD36;COL4A2;ITGA1;COL4A1;ITGA2;ITGB5;ITGB1,KEGG_2021_Human,ECM-receptor interaction,0.20344107351469595,ns,False
211,prerank,KEGG_2021_Human__Focal adhesion,-0.2452601329697423,-0.9804946860145695,0.4856115107913669,0.6390345307175163,1.0,28/97,20.28%,KDR;HGF;CAV1;COL4A2;RAC1;RAP1A;ITGA1;COL4A1;CCND1;ROCK1;MAPK3;PDGFB;PPP1R12A;VCL;FLT1;IGF1R;PTEN;ITGA2;GSK3B;ITGB5;ACTN4;FLT4;ITGB1;RHOA;MAPK1;CAPN2;ARHGAP5;PAK4,KEGG_2021_Human,Focal adhesion,0.1944756737744754,ns,False
213,prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.32985112749845324,-0.9802592930706028,0.5017421602787456,0.6332742221740519,1.0,11/23,40.05%,VAMP8;VAMP3;USE1;VAMP5;VAMP2;SNAP23;STX8;VAMP7;STX16;STX6;STX17,KEGG_2021_Human,SNARE interactions in vesicular transport,0.19840818984322403,ns,False
216,prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.24961846950913286,-0.9694996024501773,0.5162393162393163,0.6517170613005562,1.0,15/85,12.66%,LTC4S;CYP1A1;CD36;FMO1;MAOA;MIF;HSD17B11;HSP90AA1;CA4;NTHL1;MGLL;OSTC;GPD2;BPHL;SERINC1,MSigDB_Hallmark_2020,Fatty Acid Metabolism,0.18594090946059746,ns,False
225,prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.2532298204384298,-0.9351769237901784,0.5660377358490566,0.726433562936757,1.0,18/65,25.78%,CTSD;RAC1;GNAQ;GNAI1;ROCK1;MAPK3;S1PR4;PPP2R5E;PRKCE;PTEN;ASAH1;RHOA;MAPK1;SPHK2;GNA12;ACER2;HRAS;MAPK14,KEGG_2021_Human,Sphingolipid signaling pathway,0.13880409859834583,ns,False
227,prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.3438427930708453,-0.9317306803212632,0.568904593639576,0.7273054434715869,1.0,5/16,13.51%,NRP1;DPYSL2;ETS2;CDK6;NF1,MSigDB_Hallmark_2020,Hedgehog Signaling,0.13828316196682275,ns,False
233,prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.27214961305574487,-0.9135022056387547,0.5934065934065934,0.7638768275401667,1.0,14/39,25.67%,CALM2;CALM1;GNAQ;GNAS;ATF4;LDHB;PPP3CA;ITPR3;EP300;PPP3R1;FOXO1;CREB1;CAMK2G;PRKACA,KEGG_2021_Human,Glucagon signaling pathway,0.11697666424130646,ns,False
234,prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.29521861594355503,-0.9066887654275007,0.5919439579684763,0.7726529080553808,1.0,7/25,15.74%,CD36;CD34;ITGA1;KITLG;CD9;ITGA2;KIT,KEGG_2021_Human,Hematopoietic cell lineage,0.11201555649436398,ns,False
237,prerank,KEGG_2021_Human__Prostate cancer,-0.2613927337938579,-0.9005905635345309,0.6326530612244898,0.7794451509919962,1.0,19/46,26.35%,HSP90AB1;CCND1;HSP90AA1;MAPK3;PDGFB;ATF4;IGF1R;PTEN;GSK3B;ZEB1;EP300;MAPK1;FOXO1;CREB1;GRB2;CDKN1B;HRAS;CTNNB1;BAD,KEGG_2021_Human,Prostate cancer,0.10821444039767251,ns,True
238,prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.24960067757535076,-0.8924796853398835,0.6596858638743456,0.7910187027728564,1.0,21/57,26.16%,RALA;DGKZ;KITLG;ARF1;MAPK3;PDGFB;TSC2;GNAS;DGKE;PLPP3;KIT;RHOA;PLPP1;MAPK1;PLCG1;SPHK2;GNA12;GRB2;AGPAT3;HRAS;AGPAT5,KEGG_2021_Human,Phospholipase D signaling pathway,0.10181324796247124,ns,False
243,prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.24479883002508257,-0.8713101712537417,0.7021276595744681,0.8314575498329076,1.0,9/53,12.15%,THBD;COL4A2;RAC1;COL4A1;CCND1;MMP2;MAPK3;TGFBR2;PRKCE,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,0.08015991883645107,ns,False
245,prerank,KEGG_2021_Human__Spliceosome,-0.21090933274493506,-0.8587253137646634,0.7867132867132867,0.8517421055592366,1.0,31/111,34.26%,SNRPE;HSPA8;SNRPD2;SNRPD3;FUS;HNRNPM;DDX46;THOC2;LSM6;SNRNP27;SRSF4;LSM3;SNRPC;SF3B2;SRSF3;U2AF2;SF3B1;SF3B5;PRPF18;LSM7;SRSF9;LSM2;PRPF8;PRPF19;SF3A1;CRNKL1;SYF2;SNU13;SNRNP200;SNRPF;AQR,KEGG_2021_Human,Spliceosome,0.06969188303504822,ns,False
246,prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.3046000239816904,-0.8540175853555324,0.6571428571428571,0.8544747112274979,1.0,9/18,36.64%,CHST12;FUT8;CHST7;NDST1;EXTL2;CSGALNACT1;B3GAT3;CSGALNACT2;DSE,KEGG_2021_Human,Glycosaminoglycan biosynthesis,0.06830078599985244,ns,False
247,prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.2178710663027946,-0.8523178101040773,0.7745454545454545,0.8507713174902805,1.0,30/90,28.15%,STMN1;MARCKS;HMGB3;CCND1;FOXN3;HSPA8;ATRX;PURA;EWSR1;XPO1;RAD21;KIF5B;CTCF;MEIS1;SS18;RAD23B;TGFB1;NUMA1;MTF2;KPNB1;SMC4;CBX1;CDKN1B;MAPK14;H2AZ2;CUL5;CUL3;SLC12A2;MEIS2;WRN,MSigDB_Hallmark_2020,G2-M Checkpoint,0.07018716012529704,ns,False
249,prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.2959476040909553,-0.8443316684710087,0.6672661870503597,0.8595298827777865,1.0,5/20,11.22%,ADRB1;GNAI1;GNAS;MGLL;NPY,KEGG_2021_Human,Regulation of lipolysis in adipocytes,0.06573901984965012,ns,False
250,prerank,MSigDB_Hallmark_2020__DNA Repair,-0.208346611456413,-0.8384021756809618,0.8107606679035251,0.8644753183144904,1.0,15/94,12.74%,RALA;GUK1;EDF1;ARL6IP1;POLR2K;CETN2;BCAM;GTF2H5;REV3L;POLR2F;SUPT4H1;DAD1;RBX1;NME3;AK3,MSigDB_Hallmark_2020,DNA Repair,0.06324740178027324,ns,False
251,prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.2292669248451266,-0.836775982548613,0.7608695652173914,0.8603266674722927,1.0,17/59,26.35%,CALM2;CALM1;RAC1;RAP1A;YWHAE;MAPK3;ATF4;ARHGDIB;GSK3B;RHOA;MAPK1;PLCG1;GRB2;CAMK2G;HRAS;MAPK14;BAD,KEGG_2021_Human,Neurotrophin signaling pathway,0.06533661510165427,ns,False
252,prerank,KEGG_2021_Human__Th17 cell differentiation,-0.2354854833465105,-0.8265053129673801,0.7607913669064749,0.8731918174196175,1.0,17/47,26.87%,AHR;HSP90AB1;GATA3;HSP90AA1;MAPK3;TGFBR2;FOS;JAK1;PPP3CA;RXRA;RORA;MAPK1;PPP3R1;PLCG1;TGFB1;MAPK14;NFATC3,KEGG_2021_Human,Th17 cell differentiation,0.05889034266761466,ns,False
256,prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.22843858932582078,-0.812746601455941,0.791814946619217,0.8907308801284819,1.0,17/51,25.78%,GNAQ;GNAI1;GNA11;MAPK3;GNAS;ATF4;FOS;GSK3B;ITPR3;EP300;MAPK1;PLCG1;CREB1;GRB2;HRAS;PRKACA;MAPK14,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",0.05025349117039604,ns,False
259,prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.2548328650702115,-0.7843234274571779,0.7761467889908257,0.9311161080761233,1.0,5/26,14.77%,SEPTIN4;PEBP1;TALDO1;SHE;GSTM3,MSigDB_Hallmark_2020,Spermatogenesis,0.03099616010062706,ns,False
260,prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.23738306327538497,-0.7806992113379625,0.827768014059754,0.928827966661959,1.0,11/34,25.60%,IFNAR2;RAC1;MAPK3;ICAM2;PPP3CA;MAPK1;PPP3R1;PLCG1;IFNAR1;GRB2;HRAS,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,0.032064716628535155,ns,False
262,prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.27018621048171493,-0.7637441563780532,0.8217317487266553,0.9451185585296091,1.0,13/20,42.44%,ACADM;MCEE;ACAT1;ECHS1;HADH;HIBCH;ALDH3A2;ACAA1;ACADS;BCAT2;HMGCS1;HSD17B10;MMUT,KEGG_2021_Human,"Valine, leucine and isoleucine degradation",0.02451370886050523,ns,False
263,prerank,KEGG_2021_Human__Propanoate metabolism,-0.2847294247422699,-0.7627372102372079,0.7789291882556131,0.9386309615099451,1.0,10/16,42.44%,LDHB;MCEE;ACAT1;ECHS1;SUCLG1;SUCLG2;HIBCH;ACADS;ECHDC1;MMUT,KEGG_2021_Human,Propanoate metabolism,0.02750512432856605,ns,False
265,prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.23205793615082432,-0.7578799288546302,0.840630472854641,0.9374504744971638,1.0,12/35,26.87%,RASGRP3;RAC1;CD81;MAPK3;FOS;GSK3B;PPP3CA;MAPK1;PPP3R1;GRB2;HRAS;NFATC3,KEGG_2021_Human,B cell receptor signaling pathway,0.02805166676902886,ns,False
267,prerank,KEGG_2021_Human__Lysine degradation,-0.2339761157809489,-0.7535525130286902,0.8202443280977313,0.9352247821684397,1.0,11/32,32.34%,KMT2C;KMT2A;COLGALT1;ACAT1;ECHS1;NSD1;KMT5B;ASH1L;HADH;KMT2D;ALDH3A2,KEGG_2021_Human,Lysine degradation,0.029083993488215266,ns,False
268,prerank,KEGG_2021_Human__AMPK signaling pathway,-0.20961701547587683,-0.7456752999199373,0.8953900709219859,0.9373955637784973,1.0,7/51,10.95%,CD36;CCND1;RAB2A;TSC2;PPP2R5E;EEF2;IGF1R,KEGG_2021_Human,AMPK signaling pathway,0.028077106108189684,ns,False
271,prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.2519853796846524,-0.7411757691432725,0.8422876949740035,0.9351529873037119,1.0,7/24,25.78%,RAC1;MAPK3;MAPK1;PLCG1;GRB2;HRAS;MAPK14,KEGG_2021_Human,Fc epsilon RI signaling pathway,0.02911733446788742,ns,False
273,prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.2567561300260332,-0.7155469550877492,0.8604240282685512,0.9545403582188442,1.0,2/18,3.11%,MAOA;GATM,KEGG_2021_Human,Arginine and proline metabolism,0.020205704796550428,ns,False
274,prerank,KEGG_2021_Human__Base excision repair,-0.26186389428263224,-0.6969551920763559,0.8606403013182674,0.9639799393299627,1.0,5/16,23.60%,NTHL1;HMGB1;PCNA;PARP4;POLD4,KEGG_2021_Human,Base excision repair,0.01593200378280387,ns,False
276,prerank,KEGG_2021_Human__Glutathione metabolism,-0.21615010157631281,-0.6462946414048351,0.935969868173258,0.9880014982080164,1.0,9/24,29.96%,MGST3;IDH2;GPX1;GSTK1;GSTM3;GPX4;GPX7;PRDX6;MGST1,KEGG_2021_Human,Glutathione metabolism,0.005242396846601698,ns,False
279,prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.189013886075872,-0.5096539220036223,0.9859402460456942,1.0,1.0,1/16,4.50%,UXS1,KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,-0.0,ns,False
280,prerank,KEGG_2021_Human__Fatty acid degradation,-0.17414232197105275,-0.481614728559642,0.9965277777777778,1.0,1.0,9/19,38.97%,ACSL4;ACADM;ACAT1;ECHS1;HADH;ADH5;ALDH3A2;ACAA1;ACADS,KEGG_2021_Human,Fatty acid degradation,-0.0,ns,False
281,prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.10380348652931855,-0.3812321863858303,1.0,0.9998874901553886,1.0,62/62,89.74%,SAP18;FUS;PPP2R5E;MSI2;SSU72;ETF1;SMG1;UPF3A;PNN;SMG6;PAPOLA;PPP2R5A;EIF4A3;PAPOLG;NCBP2;FIP1L1;MAGOH;WDR82;SYMPK;CPSF2;SMG7;SRRM1;PPP2R1A;PPP2R3A;CPSF6;UPF1;ALYREF;PPP1CC;UPF3B;NUDT21;HBS1L;DAZAP1;GSPT1;PCF11;ACIN1;RBM8A;PPP2R3C;PPP2R5C;RNMT;UPF2;CASC3;PELO;PPP1CA;PPP2R5B;PABPC4;CPSF4;PPP2CA;PPP2R2A;PYM1;DDX39B;CLP1;SMG5;WDR33;TARDBP;PPP2R2D;CPSF7;NXT1;PABPC1;MAGOHB;PPP2CB;RNPS1;PPP1CB,KEGG_2021_Human,mRNA surveillance pathway,4.8865153631502065e-05,ns,False
278,prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.17470644904270846,0.6150460434580703,0.9952038369304557,0.9777894339993771,1.0,10/45,19.65%,NFKBIA;RELA;PIK3CA;PPP3CB;NFKBIB;BCL10;MAP2K1;VAV3;AKT1;MALT1,KEGG_2021_Human,T cell receptor signaling pathway,0.009754660036551469,ns,False
277,prerank,KEGG_2021_Human__Basal transcription factors,0.20615489324985303,0.6192442742576909,0.9516129032258065,0.9830016737113464,1.0,9/23,25.27%,TAF7;TAF9;TBPL1;GTF2H2C;TAF12;GTF2B;GTF2F1;CCNH;TAF10,KEGG_2021_Human,Basal transcription factors,0.007445742714168323,ns,False
275,prerank,KEGG_2021_Human__Peroxisome,0.2069010959970459,0.6861645185823578,0.9399538106235565,0.955894712204878,1.0,1/34,0.14%,XDH,KEGG_2021_Human,Peroxisome,0.019589940806116826,ns,False
272,prerank,KEGG_2021_Human__Longevity regulating pathway,0.20200543395298992,0.7409738420848773,0.9339622641509434,0.9125746517747458,1.0,11/53,16.40%,ADIPOR2;SOD2;EIF4EBP1;RHEB;RELA;EIF4E;PIK3CA;PRKAB1;KL;EIF4EBP2;EIF4E2,KEGG_2021_Human,Longevity regulating pathway,0.03973159862191942,ns,False
270,prerank,MSigDB_Hallmark_2020__Apical Surface,0.26271813254877696,0.7412119090126519,0.7946428571428571,0.9185903483093799,1.0,3/17,10.80%,PLAUR;ADIPOR2;CRYBG1,MSigDB_Hallmark_2020,Apical Surface,0.036878122055476546,ns,False
269,prerank,KEGG_2021_Human__Glycerolipid metabolism,0.25743582072807314,0.7453315352080534,0.8022727272727272,0.920339173282483,1.0,3/20,7.47%,PNPLA2;ALDH2;LPIN2,KEGG_2021_Human,Glycerolipid metabolism,0.036052092285784834,ns,False
266,prerank,KEGG_2021_Human__Leishmaniasis,0.23975536771257633,0.7550622610321365,0.8422273781902552,0.9155966969742438,1.0,6/30,14.61%,NFKBIA;STAT1;RELA;CR1L;NFKBIB;MARCKSL1,KEGG_2021_Human,Leishmaniasis,0.03829578271707416,ns,False
264,prerank,KEGG_2021_Human__RNA transport,0.18385778875990977,0.7582491057396268,0.95,0.9180198554910693,1.0,22/99,18.39%,EIF5;EIF4EBP1;EIF2S2;SUMO4;EIF4E;EIF3CL;RNPS1;NUP62;EIF3B;EIF3D;EIF3J;RPP14;EIF2S1;NMD3;MAGOHB;EIF4EBP2;PABPC1;NXT1;EIF4E2;EIF1;TARDBP;GEMIN7,KEGG_2021_Human,RNA transport,0.037147925512316306,ns,False
261,prerank,KEGG_2021_Human__Notch signaling pathway,0.23570281521693565,0.7777530504300045,0.7888349514563107,0.8975003101027705,1.0,2/34,1.90%,DTX3L;DLL1,KEGG_2021_Human,Notch signaling pathway,0.046965392692931485,ns,False
258,prerank,KEGG_2021_Human__Yersinia infection,0.20287116048043213,0.8016407113006933,0.874384236453202,0.8670490974103674,1.0,10/76,10.81%,NFKBIA;ARF6;ACTG1;TBK1;MAP2K3;ACTB;RELA;CCL2;PIK3CA;TRAF2,KEGG_2021_Human,Yersinia infection,0.061956309524161444,ns,True
257,prerank,KEGG_2021_Human__Amoebiasis,0.24128091674452956,0.8053085250306645,0.7945205479452054,0.867198574806783,1.0,6/35,10.12%,SERPINB9;RAB7A;CASP3;RELA;PIK3CA;CD1D,KEGG_2021_Human,Amoebiasis,0.061881444544224284,ns,False
255,prerank,KEGG_2021_Human__Inflammatory bowel disease,0.29306881117132,0.8198289481962688,0.7076923076923077,0.8480592509816526,1.0,8/18,24.20%,IL4R;STAT1;RELA;NOD2;HLA-DQA2;STAT3;HLA-DRA;NFKB1,KEGG_2021_Human,Inflammatory bowel disease,0.0715738040222462,ns,True
254,prerank,KEGG_2021_Human__Insulin signaling pathway,0.22697659586385743,0.824261883355428,0.785234899328859,0.8461736890549475,1.0,19/56,22.77%,SOCS1;SOCS2;SOCS3;EIF4EBP1;RHEB;EIF4E;PIK3CA;PPP1CB;PRKAB1;RAPGEF1;TRIP10;EIF4E2;MAP2K1;AKT1;FLOT1;G6PC3;RPS6KB1;PYGL;RAF1,KEGG_2021_Human,Insulin signaling pathway,0.07254048275785477,ns,False
253,prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.24215074026594197,0.8261363529781096,0.7253012048192771,0.8491450836403538,1.0,7/39,9.59%,NFKBIA;CCL5;ATP6V1B2;CASP3;RELA;NOD1;ATP6V0E1,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,0.0710181005201223,ns,True
248,prerank,KEGG_2021_Human__Pyruvate metabolism,0.29448529049738725,0.8492558468394358,0.6610576923076923,0.8102245704651986,1.0,2/20,3.11%,LDHA;ALDH2,KEGG_2021_Human,Pyruvate metabolism,0.09139459075542618,ns,False
244,prerank,KEGG_2021_Human__Lysosome,0.22034334158945273,0.8589209260615314,0.7352941176470589,0.7971423758810158,1.0,6/75,6.06%,LITAF;CD63;LAMP2;HYAL2;CTSL;GNS,KEGG_2021_Human,Lysosome,0.09846410327488167,ns,False
242,prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.22044878858747727,0.8738528096631453,0.7227488151658767,0.7714038361923461,1.0,9/80,8.40%,CDKN1A;GADD45G;MYC;GADD45B;ACTG1;BAK1;TXNRD1;ACTB;NQO1,KEGG_2021_Human,Hepatocellular carcinoma,0.11271820571754651,ns,False
241,prerank,KEGG_2021_Human__RNA degradation,0.2393705174117936,0.8801795364935147,0.6973094170403588,0.7633893601876784,1.0,12/55,18.57%,BTG3;HSPA9;PFKL;BTG1;XRN2;NUDT16;TTC37;TENT4A;PABPC1;BTG2;LSM8;XRN1,KEGG_2021_Human,RNA degradation,0.11725389736567442,ns,False
240,prerank,KEGG_2021_Human__Rheumatoid arthritis,0.27099173806648974,0.8893236683238177,0.6456876456876457,0.7498178472073722,1.0,8/34,9.59%,CCL5;CTSL;CSF1;ICAM1;ATP6V1B2;CCL2;VEGFA;ATP6V0E1,KEGG_2021_Human,Rheumatoid arthritis,0.1250442266892958,ns,False
239,prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.23702388033139682,0.8911003201496904,0.6666666666666666,0.7516873221357953,1.0,9/62,8.60%,MYC;ELOVL5;BHLHE40;PLAAT3;MED13L;BAG1;SIAH2;FLNB;NCOR2,MSigDB_Hallmark_2020,Estrogen Response Early,0.12396277444846031,ns,False
236,prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.2225242043930156,0.9042356867578246,0.6904761904761905,0.7285943676815331,1.0,16/103,12.98%,NFKBIA;CDKN1A;MYC;IL15RA;TNFRSF1A;CCND3;SLC25A5;ICAM1;RELA;JAK3;CCND2;PIK3CA;PPP3CB;VDAC2;NFKB2;TBPL1,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,0.1375141903467588,ns,True
235,prerank,KEGG_2021_Human__PPAR signaling pathway,0.30535814644415277,0.9055835041477975,0.6033653846153846,0.7311095576122413,1.0,2/22,2.68%,PLIN2;UBC,KEGG_2021_Human,PPAR signaling pathway,0.1360175386354503,ns,False
232,prerank,KEGG_2021_Human__Cell cycle,0.2512851872494779,0.9191317125056407,0.6049107142857143,0.7054427986771622,1.0,5/59,3.75%,CDKN1A;GADD45G;MYC;GADD45B;CCND3,KEGG_2021_Human,Cell cycle,0.15153819555387596,ns,False
231,prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.2661010247630985,0.9194800695968232,0.5985748218527316,0.7103049715086038,1.0,5/41,7.50%,PLA2G5;PLA1A;PLAAT3;LPIN2;PGS1,KEGG_2021_Human,Glycerophospholipid metabolism,0.14855514563880307,ns,False
230,prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.3183575913339508,0.9294762280624028,0.5407925407925408,0.693791400986772,1.0,4/20,7.60%,ACTG1;ITGA3;ITGAV;ACTB,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,0.1587710872081962,ns,False
229,prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.2638777565514445,0.9304824626710572,0.6133004926108374,0.6970721762759112,1.0,10/44,13.68%,H3-3B;ACTG1;SLC25A5;GSDMD;ACTB;RELA;PIK3CA;CR1L;VDAC2;CAMP,KEGG_2021_Human,Neutrophil extracellular trap formation,0.15672225183671848,ns,True
228,prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.3066755141050996,0.9315224597324956,0.5636792452830188,0.7004559386161338,1.0,8/24,19.33%,MYC;DLL1;NCOR2;CCND2;HEY2;JAG2;HEY1;JAG1,MSigDB_Hallmark_2020,Wnt-beta Catenin Signaling,0.1546191783192738,ns,False
226,prerank,KEGG_2021_Human__Tight junction,0.23764004957951645,0.9329662844992548,0.6123853211009175,0.7026740011291367,1.0,24/79,17.80%,YBX3;TUBA1C;MYL12A;CLDN5;EZR;ACTG1;VASP;TUBA4A;ACTB;CD1D;PRKAB1;TUBA1A;MSN;PPP2CB;MYL12B;ARHGEF2;SLC9A3R1;ACTN1;MYH9;ARPC1B;LLGL1;MARVELD2;PPP2R2D;TUBA1B,KEGG_2021_Human,Tight junction,0.15324611501982563,ns,False
224,prerank,KEGG_2021_Human__Glioma,0.2788794763798558,0.9397179058382596,0.575,0.6918692571113977,1.0,6/35,10.14%,CDKN1A;GADD45G;GADD45B;BAK1;PIK3CA;PDGFA,KEGG_2021_Human,Glioma,0.1599759666410594,ns,False
223,prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.25134749941981177,0.9432468417696163,0.5439429928741093,0.6893613984187607,1.0,10/60,9.95%,MYC;HIF1A;ACTG1;MED13L;ITGAV;STAT1;RHEB;ACTB;PFKL;PIK3CA,KEGG_2021_Human,Thyroid hormone signaling pathway,0.16155303906426008,ns,False
222,prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.22983528866897948,0.9433264446075517,0.579064587973274,0.6949183266336844,1.0,23/116,13.67%,UBE2G2;EIF2AK2;DDIT3;EDEM1;PPP1R15A;DNAJC3;UBXN2A;DERL1;RAD23A;BAG1;FBXO6;PREB;BAK1;UFD1;SELENOS;SAR1A;UBE2J2;DNAJB12;TRAF2;NPLOC4;HERPUD1;UBXN1;EIF2S1,KEGG_2021_Human,Protein processing in endoplasmic reticulum,0.15806623480072007,ns,False
221,prerank,KEGG_2021_Human__Drug metabolism,0.30907063667668916,0.953144946153945,0.5177777777777778,0.6774189291420574,1.0,3/25,4.79%,XDH;UPP1;IMPDH1,KEGG_2021_Human,Drug metabolism,0.1691426720151496,ns,False
220,prerank,MSigDB_Hallmark_2020__Angiogenesis,0.3351992793577431,0.9536253799776532,0.5308924485125858,0.6822277225017894,1.0,6/18,10.14%,TIMP1;PGLYRP1;ITGAV;CCND2;VEGFA;PDGFA,MSigDB_Hallmark_2020,Angiogenesis,0.16607063690028737,ns,False
219,prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.24302540773608405,0.955633614773896,0.5404157043879908,0.6833611660165623,1.0,15/81,10.42%,PLAUR;CD59;TIMP1;GADD45B;THBS1;FLNA;TAGLN;ITGAV;DAB2;TPM4;TNFAIP3;VEGFA;MGP;CCN1;IGFBP3,MSigDB_Hallmark_2020,Epithelial Mesenchymal Transition,0.16534970488159387,ns,False
218,prerank,KEGG_2021_Human__Chagas disease,0.2675420828076166,0.9608295562049656,0.5023041474654378,0.6764227340982253,1.0,12/47,18.11%,NFKBIA;TNFRSF1A;CCL5;RELA;CCL2;ACE;PIK3CA;PPP2CB;CASP8;TGFBR1;PPP2R2D;FAS,KEGG_2021_Human,Chagas disease,0.16978180449314392,ns,False
217,prerank,KEGG_2021_Human__Tuberculosis,0.2527753591666063,0.9626509245040682,0.5128205128205128,0.6775251416360331,1.0,18/77,14.89%,CEBPB;LAMP2;RAB7A;TNFRSF1A;CYCS;CEBPG;STAT1;CASP3;HSPA9;RELA;PPP3CB;CR1L;TCIRG1;CASP8;CAMP;BCL10;RIPK2;PLK3,KEGG_2021_Human,Tuberculosis,0.16907458433369893,ns,False
215,prerank,MSigDB_Hallmark_2020__Glycolysis,0.2543070046035005,0.976695222891994,0.4977973568281938,0.6486581185881615,1.0,17/77,14.16%,ISG20;DDIT4;LDHA;IER3;P4HA2;GPC4;NASP;PSMC4;GCLC;VEGFA;HDLBP;IGFBP3;PKM;TPI1;RBCK1;PPP2CB;ALDOA,MSigDB_Hallmark_2020,Glycolysis,0.18798414192369106,ns,False
214,prerank,KEGG_2021_Human__ErbB signaling pathway,0.2913794952447565,0.9773115269178969,0.4731934731934732,0.6528796314942782,1.0,4/34,9.95%,CDKN1A;MYC;EIF4EBP1;PIK3CA,KEGG_2021_Human,ErbB signaling pathway,0.18516688028146963,ns,False
212,prerank,KEGG_2021_Human__Gastric cancer,0.2743249312599926,0.9802938918299634,0.48641975308641977,0.6516874374333353,1.0,4/52,2.01%,CDKN1A;GADD45G;MYC;GADD45B,KEGG_2021_Human,Gastric cancer,0.18596065081039542,ns,False
210,prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.21568573050547635,0.9825389583821482,0.5068181818181818,0.6520499883023856,1.0,49/220,15.10%,TUBA1C;DDIT3;SETX;PSMA6;SQSTM1;TNFRSF1A;ACTG1;ANXA7;PSMA5;TBK1;CYCS;ADRM1;TUBA4A;DERL1;UQCRC1;PSMA3;PSMD11;TUBB4B;MAP2K3;PSMD3;PSMD12;CASP3;ACTB;PSMD14;PSMC4;PSMD8;ATP5F1A;PSMC1;CYC1;PSMC6;PSMD2;ATP5F1B;PPP3CB;TRAF2;NUP62;PSMD7;PSMA7;TUBA1A;GABARAP;PSMC2;COX5A;COX7A2L;TUBB6;EIF2S1;PSMC3;PSMB3;MCU;COX7C;XBP1,KEGG_2021_Human,Amyotrophic lateral sclerosis,0.1857191085446165,ns,False
209,prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.2122973851514478,0.9853344126385646,0.5081585081585082,0.6513100542079469,1.0,58/262,15.10%,UBE2L6;TUBA1C;UBE2G2;DDIT3;PSMA6;SQSTM1;UBC;TNFRSF1A;PRNP;SLC25A5;PSMA5;CSF1;TBK1;CYCS;ADRM1;TUBA4A;DERL1;UQCRC1;PSMA3;PSMD11;TUBB4B;MAP2K3;UBB;PSMD3;PSMD12;BAK1;CASP3;RELA;UBA7;PSMD14;PSMC4;PSMD8;ATP5F1A;PSMC1;CYC1;PSMC6;PSMD2;UBE2J2;ATP5F1B;PPP3CB;TRAF2;PSMD7;PSMA7;TUBA1A;GABARAP;PSMC2;VDAC2;COX5A;COX7A2L;TUBB6;CASP8;EIF2S1;PSMC3;FRAT2;PSMB3;MCU;COX7C;XBP1,KEGG_2021_Human,Pathways of neurodegeneration,0.18621221761383622,ns,False
205,prerank,KEGG_2021_Human__MAPK signaling pathway,0.23817550549111294,0.9975125303793946,0.4602803738317757,0.6271732478786588,1.0,26/129,12.12%,GADD45G;MYC;MAX;DDIT3;GADD45B;RRAS2;TNFRSF1A;CSF1;DUSP3;JUND;DUSP1;FLNA;DUSP8;MAP2K3;CASP3;RELA;FLNB;RRAS;VEGFA;DUSP16;PDGFA;DUSP6;PPP3CB;TRAF2;DUSP5;VEGFC,KEGG_2021_Human,MAPK signaling pathway,0.20261247479183203,ns,False
203,prerank,KEGG_2021_Human__Purine metabolism,0.2842572043403428,1.0016354765074063,0.43847874720357943,0.6227517326416809,1.0,4/45,4.79%,XDH;NT5C3A;PNP;IMPDH1,KEGG_2021_Human,Purine metabolism,0.20568505548045732,ns,False
202,prerank,KEGG_2021_Human__Ether lipid metabolism,0.3601672907075988,1.0025615761463569,0.46436781609195404,0.6265645822888868,1.0,2/17,3.04%,PLA2G5;PLAAT3,KEGG_2021_Human,Ether lipid metabolism,0.20303415805187155,ns,False
201,prerank,KEGG_2021_Human__mTOR signaling pathway,0.2667620310974833,1.004564904854088,0.4427860696517413,0.627798371303215,1.0,11/66,9.95%,SLC3A2;DDIT4;CASTOR1;TNFRSF1A;ATP6V1B2;EIF4EBP1;RHEB;LPIN2;EIF4E;FNIP2;PIK3CA,KEGG_2021_Human,mTOR signaling pathway,0.20217981532432286,ns,True
200,prerank,MSigDB_Hallmark_2020__E2F Targets,0.2568254253275463,1.0058992844929524,0.4383561643835616,0.6307232555910987,1.0,12/83,9.89%,CDKN1A;MYC;JPT1;HMGA1;TBRG4;NASP;UNG;POLE4;LBR;SLBP;SYNCRIP;NOP56,MSigDB_Hallmark_2020,E2F Targets,0.20016115570607879,ns,False
199,prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.2996875850940484,1.008098438575454,0.4525862068965517,0.6310966066125469,1.0,10/36,10.47%,PRNP;SBNO2;SRXN1;GCLM;SOD2;TXNRD1;NQO1;GCLC;SELENOS;CDKN2D,MSigDB_Hallmark_2020,Reactive Oxygen Species Pathway,0.19990415500730002,ns,False
198,prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.3350993174796613,1.0201290769678113,0.4376417233560091,0.6064432657518889,1.0,6/24,7.60%,ACTG1;ITGA3;ITGAV;TPM4;TPM3;ACTB,KEGG_2021_Human,Dilated cardiomyopathy,0.2172098222061309,ns,False
197,prerank,KEGG_2021_Human__FoxO signaling pathway,0.2730525328556079,1.0208079833888433,0.394919168591224,0.6109121222414503,1.0,12/63,12.18%,CDKN1A;GADD45G;GADD45B;S1PR1;TNFSF10;SOD2;CCND2;PIK3CA;CDKN2D;PRKAB1;GABARAP;PLK2,KEGG_2021_Human,FoxO signaling pathway,0.21402125713949605,ns,False
196,prerank,MSigDB_Hallmark_2020__Androgen Response,0.2828987426900327,1.0229594285443788,0.4164705882352941,0.6116358778500828,1.0,8/50,6.80%,AKAP12;ELOVL5;MYL12A;CCND3;ADRM1;ITGAV;FADS1;SLC38A2,MSigDB_Hallmark_2020,Androgen Response,0.21350704730270853,ns,False
195,prerank,KEGG_2021_Human__Shigellosis,0.23881195785672804,1.0286392459307607,0.35091743119266056,0.6032339723227653,1.0,32/140,17.26%,NFKBIA;MYL12A;SQSTM1;UBC;H3-3B;TNFRSF1A;ARF6;CCL5;ACTG1;TBK1;CYCS;UBB;ACTB;RELA;NOD1;PIK3CA;TRAF2;GABARAP;NFKBIB;RBCK1;UBE2V1;RIPK1;MYL12B;BCL10;CYTH1;RIPK2;ARHGEF2;BECN1;MDM2;ACTN1;ARPC1B;GSK3A,KEGG_2021_Human,Shigellosis,0.21951420829070878,ns,False
193,prerank,KEGG_2021_Human__Breast cancer,0.27641085044924424,1.0321300671580005,0.4046511627906977,0.6004175499432484,1.0,5/60,2.01%,CDKN1A;GADD45G;MYC;DLL1;GADD45B,KEGG_2021_Human,Breast cancer,0.22154662200485348,ns,False
191,prerank,KEGG_2021_Human__Pancreatic cancer,0.301673555993076,1.0409503407061578,0.38534278959810875,0.5850921450791773,1.0,9/44,11.85%,CDKN1A;GADD45G;GADD45B;STAT1;BAK1;RELA;VEGFA;PIK3CA;RALB,KEGG_2021_Human,Pancreatic cancer,0.2327757322971912,ns,False
187,prerank,KEGG_2021_Human__Melanoma,0.32755697548239576,1.0589364813264786,0.3695150115473441,0.5473773330656045,1.0,6/29,10.14%,CDKN1A;GADD45G;GADD45B;BAK1;PIK3CA;PDGFA,KEGG_2021_Human,Melanoma,0.2617131907190076,ns,False
185,prerank,KEGG_2021_Human__Cysteine and methionine metabolism,0.36503587383975794,1.0621777096859633,0.36036036036036034,0.5456579184614708,1.0,5/19,12.21%,LDHA;GCLM;MAT2A;GCLC;SRM,KEGG_2021_Human,Cysteine and methionine metabolism,0.26307953803410866,ns,False
184,prerank,KEGG_2021_Human__Hippo signaling pathway,0.2812325282492564,1.0665954717715749,0.33557046979865773,0.5411607806428911,1.0,12/68,10.30%,BIRC3;MYC;RASSF1;SAV1;CCND3;BBC3;ACTG1;TEAD4;ACTB;YWHAH;CCND2;PPP1CB,KEGG_2021_Human,Hippo signaling pathway,0.2666736854069453,ns,False
181,prerank,KEGG_2021_Human__Cardiac muscle contraction,0.34521566382970453,1.0712788506110937,0.3378076062639821,0.5356346380840133,1.0,8/25,16.27%,UQCRC1;TPM4;TPM3;CYC1;COX5A;COX7A2L;COX7C;COX4I1,KEGG_2021_Human,Cardiac muscle contraction,0.27113134606940054,ns,False
179,prerank,KEGG_2021_Human__Pathways in cancer,0.23693931140048316,1.0749509185635209,0.2425,0.5327625447115477,1.0,44/220,13.65%,BIRC3;NFKBIA;CDKN1A;PML;GADD45G;MYC;MAX;DLL1;GADD45B;IL15RA;RASSF1;HIF1A;LPAR6;STAT2;CCND3;BBC3;IL4R;ITGA3;CYCS;ITGAV;STAT1;TPM3;BAK1;CASP3;TXNRD1;RELA;JAK3;NQO1;DAPK1;ZBTB16;CCND2;VEGFA;PIK3CA;PDGFA;TRAF2;BCR;RALB;VEGFC;GNA13;NFKB2;GNGT2;DLL4;LAMA5;CASP8,KEGG_2021_Human,Pathways in cancer,0.27346631536343696,ns,False
178,prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.2644939772327563,1.0776283135824958,0.3056872037914692,0.5320012817840936,1.0,24/107,13.72%,NFKBIA;CDKN1A;MYC;TAP1;TAP2;TNFRSF1A;CCL5;TBK1;CYCS;ITGAV;EIF4EBP1;BAK1;CASP3;RHEB;RELA;CCL2;VEGFA;PIK3CA;PPP3CB;TRAF2;GNA13;GNGT2;CASP8;RIPK1,KEGG_2021_Human,Human cytomegalovirus infection,0.27408732133072583,ns,True
174,prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.2639210345197523,1.0849540060647287,0.265625,0.5207481655110616,1.0,17/96,10.81%,IRF7;NFKBIA;DDIT3;TNFRSF1A;TNFSF10;CCL5;TBK1;ICAM1;CYCS;MAP2K3;SOD2;CASP3;RELA;CCL2;PIK3CA;PPP3CB;TRAF2,KEGG_2021_Human,Lipid and atherosclerosis,0.2833722513078716,ns,False
172,prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.2701415576344278,1.0952688499683014,0.25235849056603776,0.5021072365429423,1.0,17/101,10.81%,NFKBIA;BST2;TAP1;TAP2;SAMHD1;TNFRSF1A;TBK1;CYCS;MAP2K3;BAK1;CASP3;RELA;CFL1;PIK3CA;CFL2;PPP3CB;TRAF2,KEGG_2021_Human,Human immunodeficiency virus 1 infection,0.29920351937845074,ns,True
171,prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.32667104005031466,1.1034279722018765,0.3185011709601874,0.48931503016792405,1.0,9/39,13.50%,NFKBIA;DLL1;IL4R;STAT1;RELA;JAK3;PPP3CB;NFKBIB;DLL4,KEGG_2021_Human,Th1 and Th2 cell differentiation,0.3104114439197299,ns,False
164,prerank,MSigDB_Hallmark_2020__heme Metabolism,0.26673425168196085,1.1223806500521842,0.19518072289156627,0.45200183359399687,1.0,14/103,9.35%,UCP2;SDCBP;LAMP2;ASNS;CCND3;SLC6A9;P4HA2;GCLM;RAD23A;MAP2K3;LPIN2;GCLC;FBXO7;TOP1,MSigDB_Hallmark_2020,heme Metabolism,0.3448598034228221,ns,False
161,prerank,MSigDB_Hallmark_2020__Coagulation,0.31228905823929776,1.1424721294078766,0.2191780821917808,0.4147580662684152,1.0,11/54,7.17%,SERPING1;LAMP2;CSRP1;TIMP1;THBS1;C2;FURIN;CLU;MAFF;C1S;RAPGEF3,MSigDB_Hallmark_2020,Coagulation,0.38220515900632057,ns,False
160,prerank,MSigDB_Hallmark_2020__Myogenesis,0.3009258945436061,1.148602322743373,0.23582766439909297,0.40666442327254637,1.0,17/72,11.36%,CDKN1A;PDLIM7;IFRD1;GADD45B;BHLHE40;PRNP;CLU;TAGLN;TEAD4;BAG1;TPM3;MYOZ1;NQO1;RIT1;IGFBP3;SVIL;GJA5,MSigDB_Hallmark_2020,Myogenesis,0.3907638198556713,ns,False
159,prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.4156911248412418,1.149010202863703,0.275609756097561,0.4106915521794142,1.0,2/16,0.46%,RSAD2;MX1,MSigDB_Hallmark_2020,KRAS Signaling Dn,0.38648423038130697,ns,False
158,prerank,KEGG_2021_Human__Viral carcinogenesis,0.29203076915368625,1.1633730391324997,0.1853546910755149,0.3870966021872663,1.0,21/94,13.73%,IRF7;NFKBIA;CDKN1A;EIF2AK2;CCND3;BAK1;CASP3;RELA;JAK3;YWHAH;HNRNPK;CCND2;PSMC1;PIK3CA;TRAF2;PKM;MRPS18B;NFKB2;TBPL1;CASP8;MAPKAPK2,KEGG_2021_Human,Viral carcinogenesis,0.4121806407652535,ns,False
157,prerank,KEGG_2021_Human__Non-small cell lung cancer,0.3457843353016206,1.163711913972152,0.23448275862068965,0.3910875681199319,1.0,7/37,9.95%,CDKN1A;GADD45G;GADD45B;RASSF1;BAK1;JAK3;PIK3CA,KEGG_2021_Human,Non-small cell lung cancer,0.4077259891686198,ns,True
155,prerank,KEGG_2021_Human__Mitophagy,0.3284259886787808,1.1708746168939206,0.2,0.38197033451129975,1.0,9/49,8.80%,SQSTM1;HIF1A;UBC;RAB7A;RRAS2;TBK1;UBB;RELA;RRAS,KEGG_2021_Human,Mitophagy,0.4179703649896769,ns,False
154,prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.29500981793506287,1.1717823100141926,0.17475728155339806,0.38503532381529987,1.0,20/88,16.73%,BIRC3;UBE2L6;PML;SOCS1;UBE2G2;UBC;SOCS3;UBB;UBA7;UBE2A;UBE2J2;SAE1;CDC34;HERC4;UBE2E1;FBXW8;UBE2F;MDM2;UBE2J1;SMURF2,KEGG_2021_Human,Ubiquitin mediated proteolysis,0.414499425726978,ns,False
146,prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.38655735404421393,1.2052662026211576,0.20654911838790932,0.3282323070210038,1.0,7/27,11.68%,MYC;LDHA;HIF1A;PFKL;PIK3CA;PKM;PGAM4,KEGG_2021_Human,Central carbon metabolism in cancer,0.48381867474416557,ns,False
144,prerank,KEGG_2021_Human__Insulin resistance,0.358262458539172,1.2102428034814106,0.1873589164785553,0.32332859659232044,1.0,8/38,12.07%,NFKBIA;TNFRSF1A;SOCS3;RELA;PIK3CA;PPP1CB;PRKAB1;CPT1A,KEGG_2021_Human,Insulin resistance,0.49035588279017794,ns,False
143,prerank,KEGG_2021_Human__Colorectal cancer,0.33630957511380327,1.2139475339020769,0.1736111111111111,0.32178657803586086,1.0,8/50,7.23%,CDKN1A;GADD45G;MYC;GADD45B;BBC3;CYCS;BAK1;CASP3,KEGG_2021_Human,Colorectal cancer,0.49243207461401856,ns,False
142,prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.3169212578265834,1.2168583130102806,0.14380530973451328,0.32095917810984587,1.0,15/64,12.35%,CDKN1A;DDIT3;SQSTM1;TNFRSF1A;STAT2;DUSP3;TBK1;MAP2K3;NOD1;EIF4E;RIT1;CFL1;TRAF2;RALB;NFKBIB,MSigDB_Hallmark_2020,PI3K/AKT/mTOR  Signaling,0.493550200769645,ns,True
141,prerank,KEGG_2021_Human__Acute myeloid leukemia,0.36834448771784734,1.2177947398079467,0.16027088036117382,0.323528993940586,1.0,7/33,10.48%,PML;MYC;EIF4EBP1;RELA;ZBTB16;PIK3CA;DUSP6,KEGG_2021_Human,Acute myeloid leukemia,0.49008679275676764,ns,False
137,prerank,KEGG_2021_Human__Legionellosis,0.3926042830159776,1.2215837974850947,0.19148936170212766,0.321531113620546,1.0,8/26,13.65%,NFKBIA;CYCS;CASP3;RELA;SAR1A;CR1L;NFKB2;CASP8,KEGG_2021_Human,Legionellosis,0.4927769953061265,ns,False
136,prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.338845197861884,1.221630190027865,0.15331807780320367,0.3258352791763622,1.0,10/49,12.35%,NFKBIA;HIF1A;CD274;MAP2K3;STAT1;RELA;BATF2;PIK3CA;PPP3CB;NFKBIB,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.48700189509769126,ns,False
134,prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.3000689642965651,1.2232790744902893,0.11056511056511056,0.3273926443777854,1.0,27/101,15.55%,NFKBIA;TUBA1C;TMBIM6;TNFRSF1A;ARF6;TNFSF10;CLDN5;EZR;ACTG1;CYCS;TUBA4A;TUBB4B;BAK1;CASP3;ACTB;RELA;ABCF2;TRAF2;TUBA1A;NFKBIB;GNA13;TUBB6;CASP8;RIPK1;CYTH1;ARHGEF2;SLC9A3R1,KEGG_2021_Human,Pathogenic Escherichia coli infection,0.4849310822301996,ns,True
133,prerank,KEGG_2021_Human__Necroptosis,0.32206582669658296,1.2271935002575574,0.14253897550111358,0.3252787662094652,1.0,17/71,14.64%,BIRC3;EIF2AK2;SQSTM1;TNFRSF1A;TNFSF10;STAT2;SLC25A5;STAT1;GLUD2;JAK3;TNFAIP3;TRAF2;VDAC2;RBCK1;CASP8;RIPK1;RNF103-CHMP3,KEGG_2021_Human,Necroptosis,0.48774428599279657,ns,False
130,prerank,KEGG_2021_Human__Human papillomavirus infection,0.29474628016099,1.2638307286605264,0.06018518518518518,0.2719025217246733,1.0,25/145,9.95%,ISG15;OASL;MX1;CDKN1A;EIF2AK2;THBS1;IRF1;TNFRSF1A;STAT2;CCND3;ITGA3;TBK1;ATP6V1B2;ITGAV;STAT1;EIF4EBP1;BAK1;CASP3;RHEB;RELA;CCND2;VEGFA;PSMC1;ATP6V0E1;PIK3CA,KEGG_2021_Human,Human papillomavirus infection,0.5655867645859756,ns,True
127,prerank,KEGG_2021_Human__Autophagy,0.33032157960597247,1.2724210167456635,0.0951219512195122,0.2634190469470954,1.0,18/77,13.67%,LAMP2;DDIT4;SQSTM1;HIF1A;RAB7A;RRAS2;CTSL;TBK1;TP53INP2;VMP1;RHEB;DAPK1;RRAS;PIK3CA;GABARAP;SH3GLB1;PPP2CB;EIF2S1,KEGG_2021_Human,Autophagy,0.5793528258626415,ns,False
125,prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.28875632213318264,1.2737238786979268,0.06779661016949153,0.26573047548063433,1.0,51/172,18.00%,IFRD1;MYC;PSMA6;LDHA;C1QBP;TOMM70;CNBP;PSMD3;EIF2S2;PCBP1;TCP1;PSMD14;PSMC4;KARS1;EIF4E;PSMD8;SYNCRIP;SLC25A3;CYC1;IARS1;NOP56;PSMC6;RNPS1;EPRS1;PSMD7;EIF3B;PSMA7;CCT7;GNL3;CCT4;SRM;COX5A;EIF3D;EIF3J;MRPS18B;RRP9;IMPDH2;HSPE1;HNRNPU;EIF2S1;DDX21;UBE2E1;PSMB3;PABPC1;AIMP2;CCT2;PSMA1;TARDBP;CCT5;ODC1;SRSF2,MSigDB_Hallmark_2020,Myc Targets V1,0.5755586353748477,ns,False
124,prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.35369232337481005,1.2752444251805641,0.08292682926829269,0.2676734673706394,1.0,11/55,9.95%,CDKN1A;TIMP1;LDHA;HIF1A;PFKFB3;EIF4EBP1;RELA;PFKL;EIF4E;VEGFA;PIK3CA,KEGG_2021_Human,HIF-1 signaling pathway,0.5723946753039132,ns,False
123,prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.43045585980818846,1.2834537060105757,0.15839243498817968,0.2596469307297573,1.0,8/23,11.25%,ACTG1;ITGA3;ITGAV;TPM4;TPM3;ACTB;ACE;PRKAB1,KEGG_2021_Human,Hypertrophic cardiomyopathy,0.5856168068066807,ns,False
121,prerank,KEGG_2021_Human__Proteoglycans in cancer,0.31986139079116294,1.2932096172292031,0.07925407925407925,0.2490438045571063,1.0,20/92,10.30%,CD63;CDKN1A;MYC;PLAUR;THBS1;HIF1A;RRAS2;EZR;ACTG1;CTSL;FLNA;HPSE;ITGAV;CASP3;ACTB;FLNB;RRAS;VEGFA;PIK3CA;PPP1CB,KEGG_2021_Human,Proteoglycans in cancer,0.6037242577064579,ns,False
120,prerank,KEGG_2021_Human__Cellular senescence,0.3288377880261571,1.2962326822709762,0.09954751131221719,0.24814583265035162,0.999,18/81,10.69%,CDKN1A;GADD45G;MYC;GADD45B;SQSTM1;RRAS2;CCND3;SLC25A5;MAP2K3;EIF4EBP1;RHEB;RELA;RRAS;CCND2;PIK3CA;PPP1CB;IGFBP3;PPP3CB,KEGG_2021_Human,Cellular senescence,0.6052930139268783,ns,False
119,prerank,KEGG_2021_Human__Chemokine signaling pathway,0.3292886776117351,1.2964293828345497,0.08780487804878048,0.2517551329654859,0.999,13/81,8.16%,CXCL11;CXCL10;NFKBIA;CCL8;CCL5;STAT2;CXCL16;CXCL9;STAT1;CCL7;RELA;JAK3;CCL2,KEGG_2021_Human,Chemokine signaling pathway,0.5990216659745005,ns,False
118,prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.36468535360392634,1.2988485602642097,0.10930232558139535,0.2522900597868991,0.999,17/48,15.85%,NFKBIA;IRF1;RRAS2;STAT2;STAT1;BCL3;RELA;RRAS;PIK3CA;PPP3CB;NFKB2;CASP8;MAPKAPK2;BCL10;RELB;PLK3;MDM2,KEGG_2021_Human,C-type lectin receptor signaling pathway,0.598099860321672,ns,False
115,prerank,KEGG_2021_Human__Antigen processing and presentation,0.4261380270021551,1.3051607809635672,0.1373873873873874,0.24695687971307778,0.999,5/26,4.28%,TAP1;TAP2;PSME1;PSME2;CTSL,KEGG_2021_Human,Antigen processing and presentation,0.607378870778768,ns,False
114,prerank,KEGG_2021_Human__Phagosome,0.33962634097497824,1.306071019857291,0.09324009324009325,0.24985165636730214,0.999,19/70,13.25%,TUBA1C;LAMP2;TAP1;TAP2;THBS1;RAB7A;ACTG1;CTSL;DYNC2H1;TUBA4A;ATP6V1B2;TUBB4B;ITGAV;ACTB;ATP6V0E1;TUBA1A;TCIRG1;TUBB6;HGS,KEGG_2021_Human,Phagosome,0.6023177670987412,ns,False
113,prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3407423996664485,1.3103786693121013,0.07862407862407862,0.2472975454608849,0.999,18/73,10.48%,CXCL10;BIRC3;AKAP12;GADD45G;PSMB8;PLAUR;LAT2;TRIB1;PPP1R15A;CMKLR1;TMEM176B;IRF8;TNFAIP3;ACE;CCND2;ZNF277;IGFBP3;DUSP6,MSigDB_Hallmark_2020,KRAS Signaling Up,0.6067801941849361,ns,False
111,prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.4204669963643799,1.335531949660384,0.0821917808219178,0.21698951448759696,0.999,9/29,12.35%,NFKBIA;TNFRSF1A;SOCS3;ADIPOR2;RELA;TRAF2;PRKAB1;CPT1A;NFKBIB,KEGG_2021_Human,Adipocytokine signaling pathway,0.6635612519127639,ns,True
110,prerank,KEGG_2021_Human__Pertussis,0.3865049340054184,1.3395622893125654,0.09523809523809523,0.21541890936300379,0.998,11/39,10.20%,SERPING1;IRF1;C4B;C2;C1S;CASP3;RELA;IRF8;NOD1;CFL1;CFL2,KEGG_2021_Human,Pertussis,0.6667161772146133,ns,False
108,prerank,KEGG_2021_Human__Endometrial cancer,0.40205911887416335,1.352641594696677,0.1004566210045662,0.20262721608059028,0.995,4/33,2.01%,CDKN1A;GADD45G;MYC;GADD45B,KEGG_2021_Human,Endometrial cancer,0.6933022223528852,ns,False
100,prerank,KEGG_2021_Human__Osteoclast differentiation,0.38762460033843316,1.3953243396672765,0.0702576112412178,0.15611010360957087,0.986,19/52,17.36%,NFKBIA;SOCS1;SQSTM1;TNFRSF1A;STAT2;CSF1;JUND;SOCS3;STAT1;RELA;PIK3CA;PPP3CB;TRAF2;NFKB2;RELB;ACP5;JUNB;TGFBR1;MAP2K1,KEGG_2021_Human,Osteoclast differentiation,0.8065689880337723,ns,False
92,prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.4077114322443746,1.4195076489050436,0.053811659192825115,0.13622844737307013,0.976,22/44,27.79%,NOB1;NOP56;XRN2;GNL3;UTP14A;FCF1;NMD3;RCL1;WDR43;NXT1;AK6;GAR1;XRN1;IMP4;RIOK1;UTP18;CSNK2B;RPP40;GNL2;NOP58;CSNK2A2;REXO2,KEGG_2021_Human,Ribosome biogenesis in eukaryotes,0.865732193105207,ns,False
91,prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.3513449913376094,1.4258562861448214,0.022988505747126436,0.13317679907440252,0.972,26/92,13.73%,IRF7;NFKBIA;CDKN1A;MYC;EIF2AK2;HIF1A;UBC;TNFRSF1A;STAT2;TBK1;ICAM1;CYCS;STAT1;UBB;BAK1;CASP3;RELA;VEGFA;PIK3CA;PPP3CB;TRAF2;RCAN1;GABARAP;GNGT2;CASP8;MAPKAPK2,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,0.8755714276551426,ns,True
89,prerank,KEGG_2021_Human__Salmonella infection,0.32721773167018364,1.4295587065217057,0.015544041450777202,0.132637994883311,0.97,39/153,14.63%,BIRC3;NFKBIA;TUBA1C;MYC;MYL12A;RAB7A;TNFRSF1A;ARF6;TNFSF10;ACTG1;DYNC2H1;FLNA;CYCS;DYNLT1;TUBA4A;AHNAK;TUBB4B;MAP2K3;GSDMD;S100A10;BAK1;CASP3;ACTB;RELA;FLNB;NOD1;ARL8A;RRAS;SNX33;PIK3CA;TRAF2;TUBA1A;KPNA4;TUBB6;CASP8;RIPK1;MYL12B;CYTH1;RIPK2,KEGG_2021_Human,Salmonella infection,0.8773320520659345,ns,True
88,prerank,KEGG_2021_Human__Basal cell carcinoma,0.5074083290844238,1.4311237504124554,0.07834101382488479,0.13373023410685433,0.97,4/17,7.11%,CDKN1A;GADD45G;GADD45B;BAK1,KEGG_2021_Human,Basal cell carcinoma,0.8737703951211911,ns,False
82,prerank,KEGG_2021_Human__Prolactin signaling pathway,0.42677323646825943,1.4422463868301232,0.0765661252900232,0.1263423869392037,0.961,8/34,9.95%,SOCS1;SOCS2;IRF1;SOCS3;STAT1;RELA;CCND2;PIK3CA,KEGG_2021_Human,Prolactin signaling pathway,0.8984509224018189,ns,False
80,prerank,KEGG_2021_Human__Bladder cancer,0.4926523496726087,1.4514350184955416,0.0589622641509434,0.12087104089427007,0.955,6/22,9.04%,CDKN1A;MYC;RASSF1;THBS1;DAPK1;VEGFA,KEGG_2021_Human,Bladder cancer,0.9176777379011326,ns,False
79,prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.495902817373197,1.4548832080314018,0.0498812351543943,0.12018361280945904,0.955,5/21,5.99%,C4B;H3-3B;C2;TRIM21;C1S,KEGG_2021_Human,Systemic lupus erythematosus,0.9201547449089926,ns,False
78,prerank,KEGG_2021_Human__Ferroptosis,0.5007984865907369,1.4612120572531386,0.06872037914691943,0.11749227242496416,0.95,10/22,18.06%,SLC3A2;PRNP;GCLM;PCBP1;MAP1LC3B2;GCLC;VDAC2;LPCAT3;ACSL5;PCBP2,KEGG_2021_Human,Ferroptosis,0.9299906964012591,ns,False
76,prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.3775052228229053,1.5032355364254704,0.009174311926605505,0.08919860229866708,0.896,19/85,11.24%,XDH;UPP1;GCH1;ELOVL5;TMBIM6;TNFRSF1A;ALDH2;SERTAD1;TMEM176B;LPIN2;IRF8;NQO1;KARS1;ALAS1;GCLC;UGDH;DDAH2;POR;NMT1,MSigDB_Hallmark_2020,Xenobiotic Metabolism,1.0496419507666126,ns,False
73,prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.4254666117698327,1.5195679011238858,0.02877697841726619,0.0808144056328691,0.868,9/47,10.86%,NFKBIA;CDKN1A;GADD45G;MYC;GADD45B;BAK1;RELA;PIK3CA;BCR,KEGG_2021_Human,Chronic myeloid leukemia,1.092511216834069,ns,False
71,prerank,MSigDB_Hallmark_2020__Complement,0.375536744280756,1.5309164271324207,0.011160714285714286,0.07632320881210353,0.851,27/99,13.58%,IRF7;CEBPB;SERPING1;LAMP2;PLAUR;CSRP1;CD59;TIMP1;IRF1;C2;CCL5;CLU;MAFF;CTSL;EHD1;C1S;CASP3;TNFAIP3;PIK3CA;PPP4C;DUSP6;VCPIP1;DUSP5;PSMB9;STX4;GNGT2;PPP2CB,MSigDB_Hallmark_2020,Complement,1.1173433791308074,ns,False
69,prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.3894305204274773,1.5408877413977293,0.0045351473922902496,0.07278749178992422,0.826,22/82,13.67%,CEBPB;ATF3;DDIT4;ASNS;EDEM1;CEBPG;TARS1;DNAJC3;EIF4EBP1;PREB;HSPA9;CCL2;TATDN2;EIF4E;VEGFA;IARS1;NOP56;DNAJA4;HERPUD1;RRP9;TTC37;EIF2S1,MSigDB_Hallmark_2020,Unfolded Protein Response,1.1379432458702252,ns,False
64,prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.5043061790869479,1.583239515149749,0.034482758620689655,0.05329540638193744,0.734,11/27,20.24%,LDHA;ALDH2;PFKL;PKM;ADPGK;PGAM4;TPI1;ALDOA;GPI;BPGM;G6PC3,KEGG_2021_Human,Glycolysis / Gluconeogenesis,1.2733102219105663,ns,False
60,prerank,KEGG_2021_Human__Hepatitis B,0.4239539625508746,1.6225573612827662,0.0049504950495049506,0.039702960915720585,0.654,14/75,8.13%,IRF7;NFKBIA;CDKN1A;DDX58;IFIH1;MYC;STAT2;TBK1;CYCS;MAP2K3;STAT1;CASP3;RELA;JAK3,KEGG_2021_Human,Hepatitis B,1.401177103780759,*,True
58,prerank,KEGG_2021_Human__p53 signaling pathway,0.4865387857360764,1.62958503702319,0.006756756756756757,0.03871113150949891,0.637,11/38,10.42%,CDKN1A;GADD45G;SHISA5;GADD45B;THBS1;CCND3;BBC3;CYCS;CASP3;CCND2;IGFBP3,KEGG_2021_Human,p53 signaling pathway,1.4121641342571312,*,False
57,prerank,KEGG_2021_Human__Thyroid cancer,0.5230243414899086,1.6302779531280103,0.013888888888888888,0.03942191585412855,0.634,6/25,7.11%,CDKN1A;GADD45G;MYC;GADD45B;TPM3;BAK1,KEGG_2021_Human,Thyroid cancer,1.4042622733935193,*,False
54,prerank,KEGG_2021_Human__Toxoplasmosis,0.4572474608061046,1.6492412616611443,0.004761904761904762,0.03406425319613884,0.572,10/52,7.74%,BIRC3;NFKBIA;SOCS1;IRGM;TNFRSF1A;CYCS;MAP2K3;STAT1;CASP3;RELA,KEGG_2021_Human,Toxoplasmosis,1.4677011278269225,*,False
51,prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.4672181591711471,1.6584429448812317,0.007462686567164179,0.03204749654337406,0.545,15/51,8.22%,CXCL11;CXCL10;IL15RA;TNFRSF1A;CCL8;TNFSF10;CCL5;CSF1;IL4R;ACKR3;CXCL16;CXCL9;CCL7;CCL2;OSMR,KEGG_2021_Human,Cytokine-cytokine receptor interaction,1.4942058906338729,*,True
49,prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.48138811298209017,1.6763015271204817,0.00683371298405467,0.02801909799057667,0.481,10/40,8.25%,ATF3;PLAUR;TP53INP1;S100A11;ACTG1;CLU;CXCL16;ATF5;FBXO6;STX5,MSigDB_Hallmark_2020,Cholesterol Homeostasis,1.5525458499217877,*,False
48,prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.42532945250939375,1.676433001526105,0.0,0.028784753037707618,0.481,19/86,10.78%,NUPR1;BIRC3;CEBPB;CDKN1A;PML;GADD45G;MYC;MAX;DDIT3;GADD45B;H3-3B;BAK1;RELA;ZBTB16;CCND2;PDGFA;IGFBP3;DUSP6;HPGD,KEGG_2021_Human,Transcriptional misregulation in cancer,1.5408374922752333,*,False
44,prerank,KEGG_2021_Human__Complement and coagulation cascades,0.5866173641819205,1.6999833816818546,0.0,0.024064258778404405,0.418,7/19,5.99%,SERPING1;PLAUR;CD59;C4B;C2;CLU;C1S,KEGG_2021_Human,Complement and coagulation cascades,1.6186275108163113,*,False
42,prerank,KEGG_2021_Human__IL-17 signaling pathway,0.502364747677325,1.7172910978860754,0.002331002331002331,0.021389001063464648,0.381,13/38,13.65%,CXCL10;NFKBIA;CEBPB;JUND;TBK1;CCL7;CASP3;RELA;CCL2;TNFAIP3;TRAF2;S100A8;CASP8,KEGG_2021_Human,IL-17 signaling pathway,1.669809497932241,*,True
39,prerank,KEGG_2021_Human__Pyrimidine metabolism,0.6371590959568766,1.7461866388903786,0.009195402298850575,0.017172721982723294,0.321,4/16,3.37%,CMPK2;UPP1;NT5C3A;PNP,KEGG_2021_Human,Pyrimidine metabolism,1.765160861019445,*,False
37,prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.45424298051385026,1.759789263688847,0.0,0.01575704956120847,0.288,28/74,15.54%,PSMA6;SLC25A5;PSMA5;CYCS;ADRM1;PSMA3;PSMD11;PSMD3;PSMD12;PSMD14;PSMC4;PSMD8;PSMC1;NOP56;PIK3CA;PSMC6;PSMD2;TRAF2;PSMD7;PSMA7;PSMC2;VDAC2;TBPL1;PSMC3;PSMB3;MCU;XBP1;BECN1,KEGG_2021_Human,Spinocerebellar ataxia,1.802525098981193,*,False
36,prerank,KEGG_2021_Human__Apoptosis,0.457773587938671,1.764430154969154,0.0,0.01591593314428399,0.28,24/75,13.72%,BIRC3;NFKBIA;TUBA1C;GADD45G;DDIT3;GADD45B;MCL1;TNFRSF1A;TNFSF10;BBC3;ACTG1;CTSL;CYCS;TUBA4A;BAK1;CASP3;ACTB;RELA;PIK3CA;TRAF2;TUBA1A;CASP8;EIF2S1;RIPK1,KEGG_2021_Human,Apoptosis,1.7981678937986783,*,True
35,prerank,MSigDB_Hallmark_2020__p53 Pathway,0.42982888561463795,1.7803478655907785,0.00234192037470726,0.013811868960204116,0.241,31/113,13.32%,UPP1;NUPR1;ATF3;TRAFD1;CDKN1A;SOCS1;TAP1;SLC3A2;DDIT3;DDIT4;PTPRE;CCND3;RHBDF2;RNF19B;IER3;PPP1R15A;TXNIP;S100A10;IER5;BAK1;CDKN2AIP;ZBTB16;CCND2;BTG1;PDGFA;SERTAD3;PRKAB1;MXD1;PLK2;PRMT2;BLCAP,MSigDB_Hallmark_2020,p53 Pathway,1.8597475506621597,*,False
32,prerank,MSigDB_Hallmark_2020__Hypoxia,0.45025253876716015,1.825989554357965,0.0,0.008460972862598906,0.159,31/99,11.79%,ISG20;PLIN2;ATF3;CDKN1A;AKAP12;PLAUR;DDIT3;KLF6;BHLHE40;DDIT4;LDHA;PFKFB3;MAFF;TES;IER3;ACKR3;DUSP1;P4HA2;PPP1R15A;ADM;GPC4;SIAH2;TNFAIP3;PFKL;VEGFA;HDLBP;BTG1;CCN1;IGFBP3;PLAC8;TPI1,MSigDB_Hallmark_2020,Hypoxia,2.0725796978868756,**,True
31,prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.4626557400205359,1.838831322663998,0.0,0.007914999432366293,0.144,28/83,14.63%,IRF7;BIRC3;GBP2;NFKBIA;GBP7;IFI16;GBP4;CCL5;STAT2;TBK1;NAMPT;STAT1;TXNIP;GSDMD;RELA;CCL2;NOD1;TNFAIP3;TRAF2;GABARAP;VDAC2;NFKBIB;RBCK1;CASP8;CAMP;RIPK1;MCU;RIPK2,KEGG_2021_Human,NOD-like receptor signaling pathway,2.1015491119475755,**,False
29,prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.5151829014726913,1.8550140711541308,0.0,0.006951283017963891,0.123,15/50,14.88%,BIRC3;NFKBIA;DDX58;GADD45G;GADD45B;TNFRSF1A;ICAM1;TRIM25;RELA;TNFAIP3;TRAF2;NFKB2;RIPK1;BCL10;RELB,KEGG_2021_Human,NF-kappa B signaling pathway,2.1579350290507433,**,False
28,prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.5206953625482251,1.857261058195543,0.0,0.007033946924123461,0.121,16/52,10.14%,CDKN1A;SOCS1;MYC;IL15RA;SOCS2;MCL1;STAT2;CCND3;IL4R;SOCS3;STAT1;JAK3;OSMR;CCND2;PIK3CA;PDGFA,KEGG_2021_Human,JAK-STAT signaling pathway,2.1528009130516708,**,True
27,prerank,MSigDB_Hallmark_2020__Apoptosis,0.46870762624177753,1.879989348566698,0.0,0.005088213920806902,0.088,23/96,7.74%,ISG20;BIRC3;GCH1;ATF3;CDKN1A;BTG3;TAP1;TIMP1;DDIT3;GADD45B;MCL1;SQSTM1;IRF1;TNFSF10;CLU;SLC20A1;IER3;DNAJC3;NEDD9;TXNIP;SOD2;CASP3;RELA,MSigDB_Hallmark_2020,Apoptosis,2.2934346381864885,**,True
26,prerank,KEGG_2021_Human__Small cell lung cancer,0.5347463549948188,1.8998895079890048,0.0,0.004088269272022241,0.071,15/46,10.81%,BIRC3;NFKBIA;CDKN1A;GADD45G;MYC;MAX;GADD45B;ITGA3;CYCS;ITGAV;BAK1;CASP3;RELA;PIK3CA;TRAF2,KEGG_2021_Human,Small cell lung cancer,2.388460507319994,**,True
25,prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.5880749158982334,1.906128290061765,0.0,0.004107576328796845,0.069,20/32,21.94%,MYC;TBRG4;UNG;NOP56;GNL3;SRM;RRP9;HSPE1;RCL1;WDR43;MRTO4;AIMP2;PES1;IMP4;NOP16;NPM1;GRWD1;PA2G4;MYBBP1A;NOLC1,MSigDB_Hallmark_2020,Myc Targets V2,2.3864143575661125,**,False
24,prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.4721046318122381,1.916265434776562,0.0,0.004012420120407728,0.064,24/89,8.96%,CXCL10;PLIN2;ARL4A;SOCS1;MYC;KLF6;GADD45B;SOCS2;BHLHE40;GBP4;FURIN;PNP;TNFSF10;CCND3;PRNP;MAFF;CSF1;IL4R;HOPX;AHNAK;ITGAV;CASP3;IRF8;CCND2,MSigDB_Hallmark_2020,IL-2/STAT5 Signaling,2.3965936004715465,**,True
22,prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.5450739939225303,1.919407507166057,0.0,0.004090923992328749,0.062,10/41,7.74%,CXCL11;CXCL10;IRF7;NFKBIA;CCL5;TBK1;CXCL9;MAP2K3;STAT1;RELA,KEGG_2021_Human,Toll-like receptor signaling pathway,2.3881785894380374,**,False
21,prerank,MSigDB_Hallmark_2020__UV Response Up,0.4677338826417346,1.9199652194985628,0.0,0.004306235781398683,0.062,21/91,7.23%,NFKBIA;GCH1;ATF3;BTG3;TAP1;TMBIM6;HYAL2;SQSTM1;IRF1;ASNS;FURIN;CNP;CCND3;EIF5;ICAM1;CEBPG;TARS1;TUBA4A;SOD2;BAK1;CASP3,MSigDB_Hallmark_2020,UV Response Up,2.365902194726885,**,False
20,prerank,KEGG_2021_Human__Hepatitis C,0.5050121715646104,1.974601263167287,0.0,0.0020352855683227603,0.028,27/81,13.72%,RSAD2;CXCL10;IRF7;NFKBIA;MX1;CDKN1A;DDX58;MYC;EIF2AK2;TNFRSF1A;STAT2;CLDN5;SOCS3;TBK1;CYCS;STAT1;BAK1;CASP3;RELA;YWHAH;PIK3CA;TRAF2;PSME3;PPP2CB;CASP8;EIF2S1;RIPK1,KEGG_2021_Human,Hepatitis C,2.6913746468585265,**,True
19,prerank,KEGG_2021_Human__Measles,0.516368289410869,1.9940905942798368,0.0,0.001724006599049868,0.022,24/71,13.67%,IRF7;NFKBIA;MX1;DDX58;IFIH1;EIF2AK2;STAT2;CCND3;BBC3;TBK1;CYCS;STAT1;ADAR;BAK1;CASP3;RELA;JAK3;TNFAIP3;CCND2;PIK3CA;MSN;NFKBIB;CASP8;EIF2S1,KEGG_2021_Human,Measles,2.7634610761415503,**,False
17,prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.6651225069440709,2.0537079906117577,0.0,0.0008395552969331389,0.011,8/24,7.74%,CXCL10;IRF7;NFKBIA;DDX58;CCL5;TBK1;ADAR;RELA,KEGG_2021_Human,Cytosolic DNA-sensing pathway,3.0759506939725823,***,True
16,prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.5211881359294346,2.0578642529495603,0.0,0.0008141142273291043,0.01,31/82,14.67%,IRF7;GBP2;WARS1;SOCS1;TAP1;TAP2;TIMP1;HIF1A;C2;CCL5;CCND3;CSF1;IL4R;AARS1;FLNA;ICAM1;CXCL9;STAT1;CCL7;BCL3;IRF8;CCL2;CCND2;CD1D;TRAF2;EIF3D;EIF3J;BCL10;RIPK2;DEGS1;B2M,MSigDB_Hallmark_2020,Allograft Rejection,3.089314655530564,***,False
15,prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.6046982621036734,2.063333735430977,0.0,0.0008722652435668974,0.01,15/42,8.22%,CXCL11;CXCL10;SOCS1;IL15RA;IRF1;TNFRSF1A;STAT2;CSF1;IL4R;SOCS3;CXCL9;STAT1;CCL7;BAK1;OSMR,MSigDB_Hallmark_2020,IL-6/JAK/STAT3 Signaling,3.0593514321531208,***,True
14,prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.702293394707789,2.0875310303179564,0.0,0.0006575537989965842,0.007,11/22,8.16%,CXCL11;CXCL10;TNFRSF1A;CCL8;TNFSF10;CCL5;CSF1;ACKR3;CXCL9;CCL7;CCL2,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3.1820687087674626,***,True
13,prerank,KEGG_2021_Human__TNF signaling pathway,0.5744885380613797,2.1104477695791664,0.0,0.0005088213920806902,0.005,28/57,19.87%,CXCL10;BIRC3;NFKBIA;CEBPB;IRF1;TNFRSF1A;CCL5;CSF1;SOCS3;ICAM1;MAP2K3;CASP3;BCL3;RELA;CCL2;TNFAIP3;PIK3CA;TRAF2;VEGFC;CASP8;RIPK1;JUNB;NOD2;MAP2K1;FAS;JAG1;AKT1;VCAM1,KEGG_2021_Human,TNF signaling pathway,3.2934346381864885,***,False
12,prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4960715107988953,2.115281056705204,0.0,0.0005550778822698438,0.005,44/126,13.18%,NUPR1;CDKN1A;WARS1;IFRD1;ELOVL5;DDIT3;BHLHE40;DDIT4;LDHA;SQSTM1;ASNS;PNP;EDEM1;TES;PPP1R15A;TBK1;ADIPOR2;NAMPT;TUBA4A;PSMA3;MAP2K3;FADS1;EIF2S2;PSMD12;TXNRD1;HSPA9;UNG;PSMD14;PSMC4;PFKL;GCLC;RIT1;ABCF2;PSMC6;EEF1E1;EPRS1;NMT1;PSME3;TPI1;PSMC2;NFKBIB;CACYBP;RRP9;HSPE1,MSigDB_Hallmark_2020,mTORC1 Signaling,3.2556460772970888,***,True
11,prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,0.7313356920399163,2.180162603159136,0.0,0.0002442342681987313,0.002,12/22,10.84%,WARS1;SARS1;GARS1;YARS1;AARS1;MARS1;TARS1;NARS1;KARS1;IARS1;HARS1;EPRS1,KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,3.6121934008109013,***,False
9,prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.5822660366037347,2.336927698614548,0.0,0.0,0.0,27/89,10.81%,IRF7;BIRC3;NFKBIA;BST2;DDX58;PML;IFIH1;TAP1;EIF2AK2;TAP2;TNFRSF1A;CCL5;STAT2;SOCS3;TBK1;CYCS;STAT1;EIF4EBP1;BAK1;CASP3;RHEB;RELA;CCL2;NECTIN2;PIK3CA;PPP1CB;TRAF2,KEGG_2021_Human,Herpes simplex virus 1 infection,5.0,****,True
8,prerank,KEGG_2021_Human__Proteasome,0.6754571210249066,2.3504776271113474,0.0,0.0,0.0,25/43,14.38%,PSMB8;PSME1;PSME2;PSMA6;PSMA5;ADRM1;PSMA3;PSMD11;PSMD3;PSMD12;POMP;PSMF1;PSMD14;PSMC4;PSMD8;PSMC1;PSMC6;PSMD2;PSMD7;PSMA7;PSME3;PSMB9;PSMC2;PSMC3;PSMB3,KEGG_2021_Human,Proteasome,5.0,****,False
7,prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.5721186079469837,2.370240216337584,0.0,0.0,0.0,47/109,14.88%,ISG15;CXCL10;IRF7;NFKBIA;CDKN1A;DDX58;GADD45G;MYC;TAP1;EIF2AK2;TAP2;GADD45B;STAT2;CCND3;TBK1;ICAM1;CYCS;ADRM1;PSMD11;MAP2K3;STAT1;PSMD3;PSMD12;BAK1;CASP3;RELA;PSMD14;JAK3;PSMC4;TNFAIP3;NCOR2;CCND2;PSMD8;PSMC1;PIK3CA;PSMC6;PSMD2;TRAF2;PSMD7;PSMC2;NFKBIB;NFKB2;CASP8;RIPK1;PSMC3;B2M;RELB,KEGG_2021_Human,Epstein-Barr virus infection,5.0,****,True
6,prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.7172669225742665,2.379546791702176,0.0,0.0,0.0,16/34,13.72%,ISG15;CXCL10;IRF7;NFKBIA;DDX58;IFIH1;DHX58;AZI2;TBK1;RNF125;TRIM25;RELA;TRAF2;NFKBIB;CASP8;RIPK1,KEGG_2021_Human,RIG-I-like receptor signaling pathway,5.0,****,False
4,prerank,KEGG_2021_Human__Influenza A,0.6360913651944788,2.5425265296865054,0.0,0.0,0.0,29/83,8.16%,RSAD2;CXCL10;IRF7;NFKBIA;MX1;DDX58;PML;IFIH1;EIF2AK2;TNFRSF1A;TNFSF10;CCL5;STAT2;CCND3;ACTG1;SLC25A5;SOCS3;TBK1;ICAM1;CYCS;DNAJC3;STAT1;ADAR;TRIM25;BAK1;CASP3;ACTB;RELA;CCL2,KEGG_2021_Human,Influenza A,5.0,****,True
3,prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.681489429693975,2.6717406964687678,0.0,0.0,0.0,35/78,8.22%,CXCL11;CXCL10;IRF7;NFKBIA;LY6E;GCH1;BST2;CDKN1A;RTP4;MYC;EIF2AK2;PLAUR;TIMP1;SLC28A2;NMI;CCRL2;KLF6;IL15RA;HIF1A;IRF1;PTPRE;TNFSF10;CCL5;CSF1;IL4R;ICAM1;NAMPT;ADRM1;ADM;CXCL9;CCL7;CMKLR1;RELA;CCL2;OSMR,MSigDB_Hallmark_2020,Inflammatory Response,5.0,****,True
2,prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6561424238449212,2.7251507266693586,0.0,0.0,0.0,52/115,9.90%,CXCL11;IFIT2;CXCL10;BIRC3;NFKBIA;CEBPB;GCH1;ATF3;LITAF;CDKN1A;DDX58;BTG3;IFIH1;MYC;TAP1;PLAUR;CCRL2;KLF6;GADD45B;IL15RA;BHLHE40;MCL1;SQSTM1;IRF1;TRIB1;PTPRE;PER1;CCL5;PFKFB3;RNF19B;MAFF;CSF1;IER3;EHD1;ACKR3;DUSP1;SOCS3;PPP1R15A;ICAM1;NAMPT;CEBPD;MAP2K3;SOD2;IER5;BCL3;SIK1;RELA;CCL2;TNFAIP3;VEGFA;BTG1;CCN1,MSigDB_Hallmark_2020,TNF-alpha Signaling via NF-kB,5.0,****,False
1,prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.859024097762086,3.368829485993451,0.0,0.0,0.0,56/82,6.92%,ISG15;RSAD2;CXCL11;IFIT2;CXCL10;IRF7;IFIT3;OASL;CMPK2;ISG20;HERC6;GBP2;UBE2L6;MX1;LY6E;HELZ2;BST2;TRAFD1;LGALS3BP;SAMD9;RTP4;PARP14;IFI44;WARS1;OGFR;IFIH1;PARP9;PSMB8;TAP1;EIF2AK2;PARP12;NMI;CCRL2;SLC25A28;PSME1;PSME2;TMEM140;GBP4;IRF1;LPAR6;DHX58;NUB1;CNP;STAT2;CMTR1;TRIM21;TRIM26;CSF1;IL4R;DDX60;NCOA7;PSMA3;C1S;TXNIP;ADAR;TRIM25,MSigDB_Hallmark_2020,Interferon Alpha Response,5.0,****,True
0,prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.8130025795933316,3.5033307345686784,0.0,0.0,0.0,86/134,9.60%,ISG15;RSAD2;CXCL11;IFIT2;CXCL10;IRF7;IFIT3;OASL;CMPK2;UPP1;ISG20;IL18BP;IDO1;HERC6;NFKBIA;UBE2L6;MX1;LY6E;GCH1;HELZ2;BST2;TRAFD1;LGALS3BP;CDKN1A;RTP4;RNF213;DDX58;PARP14;IFI44;ARL4A;PML;XAF1;WARS1;OGFR;SOCS1;IFIH1;PSMB8;SERPING1;TAP1;EIF2AK2;PARP12;GBP6;ZNFX1;NMI;NLRC5;IL15RA;SAMHD1;SLC25A28;PSME1;PSME2;GBP4;HIF1A;IRF1;DHX58;PNP;TNFSF10;CCL5;STAT2;CMTR1;TRIM21;TRIM26;IL4R;DDX60;CD274;SOCS3;ICAM1;NAMPT;PSMA3;C1S;CXCL9;STAT1;TXNIP;SOD2;CCL7;ADAR;CMKLR1;TRIM25;CASP3;IRF8;CCL2;NOD1;TNFAIP3;PELI1;BATF2;BTG1;TDRD7,MSigDB_Hallmark_2020,Interferon Gamma Response,5.0,****,True
